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ABSTRACT 
Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous connective tissue 
disorder, mainly caused by mutations in COL1A1 and COL1A2, the genes encoding collagen 
type I. The cardinal symptoms include bone fragility and varying degrees of growth retardation. 
Dental and craniofacial manifestations, with dentinogenesis imperfecta (DGI) being the major 
one, are common findings in OI. DGI exists in two forms, DGI type I – a collagenous 
manifestation associated with OI, and DGI type II – a non-collagenous disease caused by 
mutations in the DSPP gene. Clinically and radiographically the discrimination between the 
two is challenging. 
Study I of this thesis had two aims, to: (i) investigate the prevalence and incidence of DGI 
type II among Swedish children and adolescents and (ii) identify undiagnosed cases of DGI 
type I. We invited all specialist pediatric dental clinics (n=47) in Sweden to participate in the 
study. Pediatric dentists interviewed and examined patients regarding medical and dental 
aspects known to be associated with OI. The prevalence of DGI type II was estimated to be 
0.0022% (95% CI: 0.00160.0029%) or 2.2 in 100,000 individuals. Clinical and radiographic 
findings raised a suspicion of undiagnosed OI in one individual, who was later diagnosed with 
OI type IV.  
Study II was a cohort study comprising 128 unrelated individuals with OI. Panoramic 
radiographs were analyzed regarding DGI, and congenitally missing teeth. Collagen I genes 
were Sanger sequenced in all individuals. Tooth agenesis was diagnosed in 17% (hypodontia 
11%, oligodontia 6%) and was more frequent in those with DGI (p=0.016) and in those with 
OI type III, 47%, compared to those with OI types I, 12% (p=0.003) and IV, 13% (p=0.017). 
Seventy-five percent of the individuals with oligodontia harbored a mutation predicted to cause 
a qualitatively changed protein, but there was no association with type of OI, gender, or 
presence of DGI.  
Study III investigated the association between collagen I mutations and DGI, taurodontism, 
and retention of permanent second molars in a retrospective cohort of 152 unrelated children 
and adolescents with OI. DGI was diagnosed clinically and radiographically in 29% of the 
individuals (44/152) and through isolated histological findings in another 19% (29/152). In the 
individuals with a COL1A1 mutation, 70% (7/10) of those with a glycine substitution located 
C-terminal of p.Gly305 exhibited DGI in both dentitions while no individual (0/7) with a 
mutation N-terminal of this point exhibited DGI in either dentition (p=0.01). In the individuals 
with a COL1A2 mutation, 80% (8/10) of those with a glycine substitution located C-terminal 
of p.Gly211 exhibited DGI in both dentitions while no individual (0/5) with a mutation N-
terminal of this point (p=0.007) exhibited DGI in either dentition. DGI was restricted to the 
deciduous dentition in 20 individuals. Taurodontism occurred in 18% of the lower permanent 
first molars and retention of permanent second molars in 31% of the adolescents.  
Study IV comprised 11 individuals with OI and hypodontia/oligodontia who were clinically 
examined and further genetically investigated with whole-genome sequencing. We detected a 
novel homozygous nonsense variant in CREB3L1, p.Tyr428*, c.1284C>A in one boy 
previously diagnosed with OI type III. COL1A1 and COL1A2 were the only two genes with 
variants that could be detected in all individuals. However, we found rare variants of unknown 
significance in several other genes related to tooth development. Among those, a missense 
variant in AXIN2, segregating with tooth agenesis in an autosomal dominant manner in the 
family of a boy with OI type IV and oligodontia.  
Conclusions This thesis found that the prevalence of DGI type II in Sweden was significantly 
lower than previously reported, and points to the importance of excluding OI in children with 
DGI. Tooth agenesis is common in OI, and OI caused by a collagen I mutation predicted to 
induce a qualitatively changed protein is associated with oligodontia. Additive effects from 
other modifying or interacting genes may contribute to the severity of the expressed phenotype. 
Dental aberrations are more common in individuals with a qualitatively changed collagen type 
I. The varying expressivity of DGI is related to the location of the collagen I mutation.   
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INTRODUCTION 
 
Osteogenesis imperfecta (OI) is a heterogeneous heritable connective tissue disorder. 
Mutations in the genes encoding collagen type I, COL1A1 and COL1A2, are the main cause of 
these disorders. Cardinal symptoms include bone fragility and varying degrees of growth 
retardation. The spectrum or oral manifestations and their genetic causes are currently largely 
unknown. Among the oral manifestations of OI, dentinogenesis imperfecta (DGI) is the most 
common. Bone and dentin share many characteristics and have a similar composition. Collagen 
type I is the main organic component of both tissues, which is also the main organic component 
of the craniofacial bone and is thus important in craniofacial development. DGI exists in two 
forms: DGI type I – a collagenous manifestation associated with OI, and DGI type II – a non-
collagenous disease caused by mutations in the DSPP gene. Clinically and radiographically, 
discriminating between the two is challenging. Prevalence of DGI type II is unknown in 
Sweden and other countries.  
The start of this project can be traced to 1991 when the Swedish national multidisciplinary 
pediatric OI team at Astrid Lindgren Children’s Hospital at Karolinska University Hospital in 
Stockholm was formed. Dr. Barbro Malmgren was the first pediatric dentist on the team and 
made great efforts to document the clinical, radiographic, and histologic findings of the 
patients. To deepen our understanding of genotype-phenotype correlations in children and 
adolescents with OI using DNA analysis, a research collaboration was established with Uppsala 
University in 2006.  
This thesis assesses the frequency of DGI; it also investigates the spectrum of oral 
manifestations in OI and relates them to genetic findings for the purpose of broadening our 
understanding of the variability in disorder expression. 
Osteogenesis imperfecta 
OI is a clinically and genetically heterogeneous connective tissue disorder characterized 
primarily by an increased tendency for fractures throughout life. Other symptoms include 
growth deficiency, joint laxity, tendency toward prolonged bleeding, bruises, premature 
hearing loss, blue sclerae, and DGI. The reported prevalence of OI is approximately 7 in 
100,000 individuals (Lindahl et al., 2015). Severity ranges from a slight increase in fracture 
tendency to perinatal lethality (Sillence et al., 1979). Sillence categorized patients with OI into 
four main types: (I) dominantly inherited OI with blue sclerae, (II) lethal perinatal OI with 
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radiographically crumpled femora and beaded ribs, (III) progressively deforming OI, and (IV) 
dominantly inherited OI with normal sclerae. The type numbers, IIV, were based on the order 
in which the syndromes first appeared in the manuscript. A subsequent categorization was later 
performed of OI type I and IV based on absence (A) or presence (B) of DGI (Table 1). 
Table 1. Classification of OI modified from Sillence et al., (1979). 
OI 
type 
DGI* Clinical features Inheritance** 
IA - Normal or short stature 
Little or no bone deformity 
Blue sclerae 
Hearing loss common 
AD 
IB +   
II ? Severe osseous fragility, perinatally 
lethal 
AD (de novo mutations) 
AR (rare) 
III +/- Very short stature 
Progressively deforming bones 
Scleral hue varies 
Hearing loss less common than type I 
AD 
AR (uncommon) 
IVA - Variable short stature 
Mild to moderate bone deformity 
Normal sclerae 
Hearing loss less common than type I 
AD 
IVB +   
*DGI = dentinogenesis imperfecta; **AD = autosomal dominant; 
AR = autosomal recessive 
 
The etiology of OI is either directly or indirectly related to disturbances in collagen type I, the 
main organic component of bone and dentin. Approximately 95% of all collagen content of 
bone and about 80% of total bone protein is collagen type I (Viguet-Carrin et al., 2006). The 
collagen type I molecule is composed of three α chains: two α1 chains and one α2 chain. These 
chains are synthesized as procollagen from COL1A1 (17q21.33) and COL1A2 (7q21.3), located 
on chromosomes 17 and 7, respectively. The first genetic cause of OI to be described, an 
internal deletion located in COL1A1, was observed in an individual with OI type II in 1983 
(Chu et al., 1983). The allelic heterogeneity seen in OI was elucidated in following years. 
Variants in COL1A1 and COL1A2, the genes encoding collagen type I, were detected in the 
majority of affected individuals.  
In some families, however, the genetic cause was unknown. The first recessive variant 
responsible for OI type II was identified in the CRTAP gene in 2006 (Barnes et al., 2006). 
Autosomal dominant mutations in COL1A1 or COL1A2 have traditionally been thought to 
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cause over 90% of OI cases (van Dijk et al., 2012, Pepin & Byers, 2015). However, more recent 
studies indicate a lower prevalence (Bardai et al., 2016). Dominant mutations in IFITM5 and 
WNT1 may also cause OI (Semler et al., 2012, Cho et al., 2012, Laine et al., 2013). In other 
cases, pathogenic variants in non-collagenous genes are the cause of recessive forms of the 
disorder. An X-linked recessive mutation has also been identified. To date, mutations in 17 
genes have been associated with OI. The recessive variants are found in genes that are involved 
in collagen biosynthesis, processing, and posttranslational modifications (Kang et al., 2017). 
This new knowledge of the genetic heterogeneity stressed the need for an updated, 
complementary grouping; the original Sillence criteria were mainly based on clinical and 
radiographic findings. At the 2009 meeting of the International Nomenclature group for 
Constitutional Disorders of the Skeleton, the original four groups were expanded by a fifth, OI 
type V (Van Dijk & Sillence, 2014). The classification is phenotypic, and the groups are 
genotypically heterogeneous (Table 2).  
Collagen defects in osteogenesis imperfecta 
Individuals of European descent with OI type IIV are heterozygous for mutations in the 
COL1A1 and COL1A2 genes in most cases. Sibling recurrences without an affected parent may 
be due to gonadal mosaicism for heterozygous dominant mutations (Van Dijk & Sillence, 
2014). Autosomal recessive variants are more common in cases of consanguinity. Two main 
classes of mutations in collagen type I result in OI – those causing a quantitatively changed 
protein and those inducing qualitative changes in collagen type I. Quantitative defects are 
characterized by about a 50% reduction of normal type I procollagen secretion; qualitative 
defects are characterized by secretion of structurally abnormal type I procollagen molecules 
(Wenstrup et al., 1990). The first class of mutations usually produces premature termination 
codons (PTC) in the coding sequence of one COL1A1 allele (Marini et al., 2007). These PTCs 
cause nonsense mediated decay of the mRNA derived from that allele and a premature 
termination of translation (Willing et al., 1992, Willing et al., 1996, Redford-Badwal et al., 
1996). This results in matrix insufficiency and the phenotype of OI type I.  
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Table 2. New osteogenesis imperfecta (OI) nomenclature. Modified from (Van Dijk 
& Sillence, 2014). 
Type Gene MIM # Locus Protein product Inheritance 
Non-deforming OI, blue sclerae 
1 COL1A1 
COL1A2 
166200 
166200 
17q21.33 
7q22.3 
Collagen α1(I) chain 
Collagen α2(I) chain 
AD 
AD 
Common variable OI, normal sclerae 
4 COL1A1 
COL1A2 
166200 
166200 
17q21.33 
7q22.3 
Collagen α1(I) chain 
Collagen α2(I) chain 
AD 
AD 
 WNT1 615220 12q13.12 Wingless-type mouse mammary 
tumor virus (MMTV), integration 
site family, member 1  
 
 CRTAP 610682 3p22.3 Cartilage-associated protein 
(CRTAP) 
AR 
 PPIB 259440 15q22.31 Cyclophilin B (CyPB)  AR 
 SP7 613849 12q13.13 Osterix AR 
 PLS3 300910 Xq23 Plastin 3 XL 
OI, calcification in interosseous membranes 
5 IFITM5 610967 11p15.5 Interferon-induced transmembrane 
protein 5 
AD 
Progressively deforming 
3 COL1A1 
COL1A2 
166200 
166200 
17q21.33 
7q22.3 
Collagen α1(I) chain 
Collagen α2(I) chain 
AD 
AD 
 BMP1 614856 8p21.3 Bone morphogenetic protein 1 AR 
 CRTAP 610682 3p22.3 Cartilage-associated protein 
(CRTAP) 
AR 
 FKBP10 610968 17q21.2 Peptidyl-prolyl cis-transisomerase 
(FKBP10) 
AR 
 LEPRE1 610915 1p34.2 Prolyl 3-hydroxylase 1 (P3H1) AR 
 PLOD2 609220 3q24 Procollagen-lysine, 2-oxoglutarate, 
5-dioxygenase 2 
AR 
 PPIB 259440 15q22.31 Cyclophilin B (CyPB)  AR 
 SERPINF1 613982 17p13.3 Pigment-epithelium-derived factor 
(PEDF) 
AR 
 SERPINH1 613848 11q13.5 Heat shock protein 47 (HSP47) AR 
 TMEM38B 615066 9q31.1 Trimeric intracellular cation 
channel B (TRIC-B) 
AR 
 WNT1 615220 12q13.12 Wingless-type mouse mammary 
tumor virus (MMTV) integration 
site family, member 1  
AR 
 CREB3L1 616229 11p11.2 Old astrocyte specifically induced 
substance (OASIS) 
AR 
Perinatally lethal 
2 COL1A1 
COL1A2 
166200 
166200 
17q21.33 
7q22.3 
Collagen α1(I) chain 
Collagen α2(I) chain 
AD 
AD 
 CRTAP 610682 3p22.3 Cartilage-associated protein 
(CRTAP) 
AR 
 LEPRE1 610915 1p34.2 Prolyl 3-hydroxylase 1 (P3H1) AR 
 PPIB 259440 15q22.31 Cyclophilin B (CyPB) AR 
AD, Autosomal dominant; AR, Autosomal recessive; XL, X-linked 
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Qualitative defects are often caused by substitutions for one of the glycine residues in the triple 
helical domain in one of the α1 or α2 chains (Kuivaniemi et al., 1997, Forlino & Marini, 2000). 
The mutations cause broad expressivity of OI. In the coding sequence of the triple helical 
domain, which can be written GGNNNNNNN338, substitutions at either G will cause a 
substitution for glycine. Substitutions at two out of every nine nucleotides will result in a 
clinically apparent phenotype (Marini et al., 2007). Based on current knowledge of genotype-
phenotype correlations, this factor should not be the only deciding variable in pregnancy 
termination.   
Alterations in splice sites are common in OI (Kuivaniemi et al., 1997). These changes can cause 
intronic inclusion, exon skipping or activation of cryptic splice sites in introns or exons.  The 
effects on mRNA and protein depend on whether the alterations are in-frame or produce 
translational frameshifts. Qualitative defects have more deleterious consequences for the 
extracellular matrix (ECM) than quantitative defects (Forlino & Marini, 2000). A small group 
of insertions, deletions, and duplications in the collagen helix as well as alterations in the C-
terminal propeptide may also have a resulting OI phenotype. 
Diagnostics of OI 
A thorough medical and family history, a physical examination, a radiographic evaluation, and 
laboratory testing are often needed in order to set a positive diagnosis of OI (Byers et al., 2006). 
The timing of the diagnosis and extension of the investigation depend on several factors. More 
severe cases of OI (types II, III, and severe type IV) may often be detected by fetal ultrasound 
examination and confirmed by genetic analysis. In childhood, typical radiographic findings of 
moderate to severe OI include bowing of the humerus and femora, and wormian bones in 
cranial sutures. Fractures, vertebral compression, and osteopenia frequently occur. The 
diagnosis of milder forms may be more challenging. In these cases, presence of DGI, blue 
sclerae, short stature, and joint hypermobility may be important findings. Bone mineral density 
can be assessed by dual-energy X-ray absorptiometry. Finally, DNA-based tests using blood 
or saliva as a source can be important tools for confirming a diagnosis.  
Treatment of children with OI 
Due to the wide range of severity, individualization of treatment is important. A combination 
of treatment modalities is often needed and leading OI-centers use a multidisciplinary team 
approach. New insights into the field of muscle-bone interactions (crosstalk) support the 
importance of loading of the skeleton preferably by standing and walking. Medical treatment 
of OI with intravenous bisphosphonates has been used since 1991 in individuals with severe 
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forms of OI (Astrom & Soderhall, 1998, Glorieux et al., 1998, Rauch et al., 2003). 
Bisphosphonates inhibit osteoclasts and bone resorption which can increase bone mass and 
density (Rauch et al., 2003). When indicated, treatment onset can be early in infancy. Physical 
and occupational therapies are important for improving activities of daily life and motor 
function and for exercise of the cardiovascular system. Osteotomies and insertion of 
intramedullary rods are often needed in more severe forms of OI for stabilization and correction 
of long bone deformities.  Rodding can also be used in milder cases with repeated long bone 
fractures. 
Collagen biosynthesis 
Collagen type I is the major organic component of bone and dentin, and the protein product 
that is affected in OI and DGI type I. The synthesis of collagen type I is a complex process 
involving several crucial steps. Collagen type I is a heterotrimer composed of two α1 chains 
and one α2 chain that are wrapped around each other in a rope-like manner, thus forming a 
triple helix (Fig. 1). The α chains are encoded by two genes, COL1A1 and COL1A2, located on 
chromosomes 17 and 7, respectively. Both genes contain more than 50 exons coding for the 
protein sequence. The major part of the protein is composed of the triple helical domain 
comprising 1014 amino acids that are encoded by 43 exons. The region encodes sequences of 
repeating triplets of the tripeptide Gly-Xaa-Yaa, where Gly is glycine and X and Y are often 
proline and lysine residues. The remaining exons are located in the amino (N)-terminal and 
carboxy (C)-terminal domains of the genes. These exons encode the signal sequence and 
proteolytic cleavage sites (N-terminal region), and a proteolytic cleavage site and a globular 
domain of importance for molecular assembly in the C-terminal portion of the gene (Byers et 
al., 1991).  
The mRNA transcripts of COL1A1 and COL1A2 are translated in the rough endoplasmic 
reticulum. The α chains subsequently undergo posttranslational modification including 
hydroxylation and glycosylation of proline and lysine residues by a number of hydroxylases. 
Once the C-terminal propeptides of the chains are synthesized, intra-chain disulfide bonds are 
formed. The propeptides are essential for the correct selection and 2:1 proportion of the α 
chains, and the triple helix nucleus is stabilized by the disulfide bonds (Marini et al., 2017). 
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Figure 1. Collagen type I structure. The molecule is a heterotrimer composed of two α1 chains 
and one α2 chain. N- and C-terminal propeptides are retained during secretion of the 
procollagen molecules but are proteolytically cleaved after secretion. Glycine is mandatory at 
every third position and is flanked by other amino acids, most often proline and hydroxyproline 
(X and Y). Posttranslational modification of proline is characterized by hydroxylation and 
glycosylation that is necessary for the stability of the triple helix. Major ligand-binding regions 
(MLBR) are regions important for the interaction of collagen type I with other collagen-related 
molecules and the ECM. Adapted from Marini et al. (2017).  
 
Hydroxylation and glycosylation of the chains continue until a stable helix structure is formed. 
When this happens, the helix is no longer a substrate (Byers et al., 1991). It is essential for the 
integrity of the molecule that there is a glycine in every third position. The reason is that this is 
the only amino acid that sterically fits into the center of the triple helix. N- and C-terminal 
propeptides flank the central helical portion of the molecule (Marini & Blissett, 2013). Once 
the procollagen chains are assembled and the posttranslational modification of lysyl and prolyl 
residues is completed in the endoplasmic reticulum, procollagen molecules are transported to 
the Golgi apparatus. The procollagen molecules are packed into vacuoles and transported to 
the cell membrane. From here, the molecules are secreted into the pericellular space, and the 
mature collagen molecule is formed by proteolytic cleavage of the N- and C-terminal ends 
(Kuznetsova & Leikin, 1999). The monomers finally self-assemble into heterotrimeric collagen 
fibrils in the ECM. The fibrils are stabilized by inter- and intra-chain covalent crosslinking 
between specific domains. The formation and organization of fibrils are dependent on normal 
collagen type I molecules, and incorporation of abnormal molecules may have deleterious 
effects on the tissue.  
To put the findings of this thesis in their correct context, fundamental knowledge of several 
tissues and developmental processes are necessary. These areas include bone formation and 
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structure, craniofacial development, tooth development, and dentin formation and composition 
in health and disease.   
Bone 
Hydroxyapatite (Ca10(PO4)6(OH)2 makes up the majority of the mineral phase, approximately 
7090%. The organic phase is composed of approximately 90% collagen type I, 5% non-
collagenous proteins, and 2% lipids by weight (Young, 2003). Collagen type I acts like 
reinforcing bars in concrete and is essential for skeletal resistance to bending and torsion. The 
high amount of hydroxyapatite crystals in bone provide mechanical rigidity and the strength to 
withstand compression forces (Wang et al., 2001). Humans have two main types of bone: 
cortical (80%) and cancellous/trabecular (20%) bone. Cortical bone is solid, making up the 
outermost part of the bones, while cancellous bone is more porous and harbors the bone 
marrow. Several cell types are relevant to bone tissue, including osteoblasts, osteoclasts, bone 
lining cells, and osteocytes. Bone is an active tissue that is constantly remodeled during life. 
This process is orchestrated by the bone remodeling unit consisting of resorptive osteoclasts, 
osteoid-secreting osteoblasts, and osteocytes (terminally differentiated osteoblasts embedded 
in the bone matrix). 
Alveolar bone 
The alveolar bone, along with the periodontal ligament (PDL) and cementum, are the tissues 
that support the teeth. Alveolar bone, which forms the maxilla and the mandible, arises through 
intramembranous bone formation (Kruijt Spanjer et al., 2017). This differs from the 
embryogenesis of long bones, which requires endochondral bone formation (Mackie et al., 
2008). Once formed, alveolar bone is composed of cortical bone separated by cancellous bone; 
the concentration of collagen type I is high. Collagen type I is organized in parallel fibrils that 
form the lamellae. The cortical bone of the alveolar processes is similar to bone in other parts 
of the skeleton. It contains Haversian systems with blood vessels and nerves that are important 
for bone remodeling and maintenance. The cancellous bone harbors hematopoietic cells, 
osteogenic cells, and adipose tissue. 
Tooth development 
Teeth are the result of an intricate system of morphogenetic tissue interactions in the embryo 
and child. These interactions are strictly regulated, sequential, and reciprocal; they are mediated 
by several transcription factors and conserved families of signaling molecules including 
Wingless-type MMTV integration site family members (Wnts), sonic hedgehog (Shh), bone 
morphogenetic proteins (BMPs), and fibroblast growth factors (FGFs) (Balic & Thesleff, 
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2015). Tooth development is characterized by reciprocal interaction between epithelial and 
mesenchymal tissue (Thesleff, 2006). Morphologically and molecularly, early tooth 
development resembles the development of other organ systems (Fig. 2). 
This regulatory communication between tissues is essential; it regulates the initiation and 
morphogenesis of teeth and affects differentiation of ameloblasts and odontoblasts, the cells 
responsible for secretion of the enamel and dentin matrices (Thesleff, 2003, Thesleff & 
Nieminen, 1996, Thesleff et al., 2007, Balic & Thesleff, 2015).  
 
 
Figure 2. Schematic summary of tooth development. Sequential reciprocal interaction 
between the epithelial and mesenchymal tissues governs the morphogenesis of the tooth 
organ. Dentinogenesis starts during the advanced bell stage. After a layer of dentin has 
been formed, amelogenesis continues. All stages are dependent on the correct expression 
of several genes encoding signaling molecules and transcription factors. BMP, Bone 
morphogenetic protein; FGF, Fibroblast growth factor; SHH, Sonic hedgehog; WNT, 
Wingless-type MMTV integration site family; TNF, Tumor necrosis factor. Modified from 
(Thesleff, 2003). 
 
In the initial stages of tooth development, the ectoderm buds into the neural-crest derived 
mesenchyme. Signals are sent from the ectoderm to the mesenchyme, which then condenses 
around the epithelial bud during the bud stage as epithelial signaling centers appear. 
Morphogenesis continues during the cap stage as the epithelium folds and grows to surround 
the dental papilla mesenchyme. Folding continues in the bell stage when the odontoblasts and 
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ameloblasts differentiate at the interface of the epithelium and mesenchyme. The secretion of 
dentin and enamel to form an ECM begins in this stage of tooth development (Thesleff, 2003).  
The initial capacity for tooth formation resides within the epithelial tissue (Mina & Kollar, 
1987). The epithelial signaling centers, primary enamel knots, express a significant number of 
signaling molecules. Tooth development starts by the expression of BMPs and FGFs that 
induce the expression of several transcription factors (Msx1, Msx2, Pax9, Dlx1, Dlx2, Lhx6, 
Lhx7, and Runx2) in the mesenchyme necessary for further odontogenesis. The induction of 
the mesenchyme results in a response to the oral epithelium to form the dental placode. Only 
the BMP and FGF families of signaling molecules perform a bidirectional signaling between 
the mesenchymal and epithelial tissues. One example is the expression of the transcription 
factor Runx2, mediating the expression of mesenchymal Fgf3 as a response to epithelial 
expression of Fgf4 (Aberg et al., 2004). 
The Wnt/β-catenin signaling is important for transition from dental lamina to the placode stage. 
Inhibition of Wnt signaling by overexpression of Dkk1 arrests tooth development at the dental 
lamina stage (Liu et al., 2008). Overexpression of β-catenin drives continuing formation of 
ectopic signaling centers (Jarvinen et al., 2006). The transition from bud to cap stage is 
regulated by mesenchymal expression of BMP4 resulting in formation of the enamel knot by 
induction of p21, causing the knot cells to exit the cell cycle (Jernvall et al., 1998). 
Eda, a TNF signaling molecule, regulates development of ectodermal appendages. It has been 
shown that Eda plays important roles in intraepithelial signaling and in regulation of the 
signaling centers (Laurikkala et al., 2001, Haara et al., 2012). Wnt signaling governs Eda 
expression. Edar, the Eda receptor, is activated in the enamel knot in response to Eda. The Eda-
Edar interaction regulates the formation and signaling activity of the enamel knots. The enamel 
knots regulate further tooth morphogenesis by producing signaling molecules and inhibitors, 
thus inducing responses in the epithelial and mesenchymal tissue. Shh is the only member of 
the hedgehog family expressed during odontogenesis. Expression of the SHH gene is 
mandatory for inducing the cervical loops. Signaling from the primary enamel knots initiates 
the secondary enamel knots, positioned at the future cusp tips, which continue to express a 
similar arsenal of signaling molecules. This perpetuates  reciprocal epithelial-mesenchymal 
communication (Thesleff, 2003).  
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Dentin  
On a weight basis, dentin constitutes approximately 70% mineral and 20% organic material; 
on a volume basis, approximately 50% and 30%. The remainder is water. Thus, dentin has a 
somewhat higher concentration of minerals than bone tissue. Bone and dentin have similar 
physical and chemical properties. A significant morphological difference, however, is that in 
bone, a proportion of the osteoblasts are embedded in the bone tissue while the dentin matrix 
only contains the processes of the odontoblasts. Dentin is a complex tissue presenting with 
several morphologically different types of calcified tissues. Primary dentin is produced at a 
high rate during tooth formation and constitutes the major part.  
Formation 
Dentin is derived from mesenchymal cells of the dental papilla. Before terminal differentiation, 
the papilla cells synthesize type I, type I trimer, and type III collagen, glycosaminoglycans, 
glycoproteins, and proteoglycans. Odontoblast differentiation is characterized by the exit of 
cells from the cell cycle and the subsequent polarization and secretion of predentin (Ruch et 
al., 1995). During functional differentiation, a change in the composition of collagen occurs as 
the secretion of collagen type I and type I trimer increases while the synthesis of collagen type 
III decreases. Synthesis of phosphoproteins, glycoproteins, glycosaminoglycans, fibronectin, 
and proteoglycans occurs simultaneously (Linde & Goldberg, 1993). Functional odontoblasts 
align in a single layer of columnar cells on the periphery of the pulp.  
Structure 
First, the functional odontoblasts secrete a layer of uncalcified matrix, the predentin. The 
predentin is subsequently mineralized to form dentin. The first layer to be deposited, the mantle 
dentin, located adjacent to the enamel, is the first to be calcified (Fig. 3). The more centrally 
located dentin is called circumpulpal dentin. As the dentin matrix is deposited, the odontoblast 
cell body is pushed away from the dentin surface (Butler & Ritchie, 1995) 
Collagens in dentin 
In dentin, collagen type I is the predominant type of collagen. Lesser amounts of collagen type 
III, V, and VI are also found. Procollagen is mainly secreted from the portion of the 
odontoblastic process located in the predentin (Weinstock & Leblond, 1974, Rabie & Veis, 
1995). 
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Figure 3. Odontoblasts secreting predentin, composed principally of collagen type I. The 
predentin is later mineralized by secretion of non-collagenous proteins. The exact routes of 
secretion are not fully elucidated. From Butler and Ritchie (1995). 
  
After exocytosis of the procollagen molecules into the ECM, the N- and C-terminal propeptides 
of the molecules are cleaved. After collagen is secreted, there is a delay before mineralization. 
Mineralization is initiated in the “empty” spaces within the collagen fibrils as inorganic calcium 
phosphate ions are deposited within and around the fibrils. There is an intricate interaction 
between the hydroxyapatite crystals and collagen fibrils, where the collagen network acts like 
a framework but also limits the amount of mineral that can be deposited. The non-collagenous 
proteins are important during this process.  
Non-collagenous proteins 
The non-collagenous proteins of dentin consist of osteocalcin, osteonectin, and the family of 
small integrin-binding ligand, N-linked glycoproteins (SIBLINGs) (MacDougall et al., 2006). 
Osteopontin, bone sialoprotein, matrix extracellular phosphoglycoprotein, dentin matrix 
protein, and dentin sialophosphoprotein (DSPP) all belong to the SIBLINGs (MacDougall, 
2003, MacDougall et al., 2006). DSPP is encoded by the DSPP gene (4q22.1). Dentin 
sialoprotein (DSP) and dentin phosphoprotein (DPP) are the two major non-collagenous 
proteins formed from the initial translated propetide (Barron et al., 2008). It has been suggested 
that DPP has a crucial role in the nucleation of hydroxyapatite crystallites. After cleavage it 
moves to the mineralization front where it interacts with collagen type I (Butler, 1998). The 
exact mechanisms of DSP function remain to be elucidated. Proteoglycans secreted by the 
odontoblasts interact with collagen type I during fibril formation and may be important for 
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regulating the size and orientation of the fibrils. These proteins may also have a role in the 
timing and the site of mineralization due to their ability to retain calcium and shield mineral 
nucleation sites in the predentin matrix.  
Dentinogenesis imperfecta 
DGI is a hereditary dentin dysplasia that occurs due to an abnormal formation of dentin. The 
diseases have traditionally been classified according to Shields et al. (1973). DGI type I was 
the syndromic form associated with OI, and DGI types II and III were isolated forms. Over 
time, the Shield classification has become insufficient to describe the spectrum of clinical and 
radiographic phenotypes; some individuals present with overlapping phenotypes. The 
identification of the genetic cause, located in the DSPP gene (4q22.1) (Xiao et al., 2001, Zhang 
et al., 2001), have further stressed the need to update the classification system. In more recent 
publications, it was concluded that the same mutation in DSPP caused an overlapping 
phenotype of DGI-II and DGI-III and it was proposed that these entities were not distinct 
diseases, but a phenotypic variation of the same disease (Kim et al., 2005). A more recent 
publication has proposed a new classification of the hereditary dentin dysplasias including 
clinical, radiographic, and genetic findings (Table 3) (de La Dure-Molla et al., 2015). 
 
Table 3. Classification of hereditary dentin dysplasias according to Shields et al. 
(1973) and de La Dure-Molla et al. (2015). Dentinogenesis imperfecta type I 
remains a condition associated with osteogenesis imperfecta.  
OMIM* Shield classification of isolated 
dentin diseases 
Proposed classification of 
isolated dentin diseases 
125400 Dentin dysplasia type I Radicular dentin dysplasia 
Dentinogenesis imperfecta 
125420 Dentin dysplasia type II Mild form 
125490 Dentinogenesis imperfecta type II Moderate form 
125500 Dentinogenesis imperfecta type III Severe form 
*OMIM = Online Mendelian Inheritance in Man 
 
DGI-I 
Clinical findings 
Clinically, teeth affected by DGI-I present with a spectrum of hues varying from opalescent 
with a gray-blue hue to yellow-brown with an amber hue (Shields et al., 1973, Ranta et al., 
1993, O'Connell & Marini, 1999, Barron et al., 2008). Extensive inter- and intraindividual 
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variations in the phenotypic expression of the colors can occur in both dentitions (Levin et al., 
1980, O'Connell & Marini, 1999, Malmgren & Norgren, 2002). The deciduous dentition is 
more severely affected, but the cause is unknown (Fig. 4). The enamel has normal structure 
and mineral content but is easily dislodged due to the soft underlying dentin. The exposed 
dysplastic dentin is prone to severe and rapid attrition.  
Radiographic findings 
Pathognomonic radiographic manifestations are seen in DGI. These include abnormalities in 
crown shape, cervical constrictions, short constricted roots, and abnormally large or calcified 
pulp chambers (Shields et al., 1973, Lukinmaa et al., 1987b, Malmgren & Norgren, 2002) . 
Onset of pulp obliteration has been observed to occur before the teeth have erupted, indicating 
that the process is due to the disease and not mechanical stress. 
Histologic findings 
Histologic findings in teeth affected by DGI differ between individuals. The enamel is normal 
in structure, and the dentin-enamel junction may be flattened or scalloped. Dysplastic dentin 
expression includes varying degrees of sparse, thin, and irregular dentin tubules; variations in 
dentin tubuli width and branching; hyaline dentin void of dentin tubuli; dentin layering; and 
presence of cell lacunae in the body of dentin (Malmgren & Lindskog, 2003). Peripheral mantle 
dentin is often less severely dysplastic compared to the circumpulpal dentin, which is formed 
later. Dentin layering occurs in incremental lines with irregular amounts of collagen. Canal-
like structures containing amorphous material and cellular inclusions are frequent findings in 
more severely affected teeth (Sunderland & Smith, 1980, Lukinmaa et al., 1987a, Waltimo et 
al., 1996, Malmgren & Lindskog, 2003). 
 
 
Figure 4. Clinical findings in a 13-year-old girl with OI type I. The permanent mandibular 
incisors are the teeth that are most severely affected. Anterior crossbite and unilateral open 
bite are seen. Several permanent tooth germs are congenitally missing.  
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Differences between DGI-I and DGI-II 
Clinical, radiographic, and histologic findings in DGI-I and DGI-II are similar, and thus 
challenging to differentiate (Fig. 5). The main differences include presence of OI in DGI-I. A 
more extensive intraindividual variability of expression is found in DGI-I and an almost 
complete penetrance is seen in DGI-II (Witkop, 1971, Shields et al., 1973). However, the 
genetic causes are different between the two types. Mutations in COL1A1 and COL1A2 give 
rise to DGI-I (Pallos et al., 2001), and a mutation in the DSPP gene (4q22.1), to DGI-II (Xiao 
et al., 2001, Zhang et al., 2001). 
    
Figure 5. Clinical and radiographic findings in an 11-year-old boy with a severe form of 
DGI-II.  
 
Differential diagnosis of DGI 
The clinical features of several conditions are similar to those of DGI, which may cause some 
confusion when setting a diagnosis. These include tetracycline-induced discoloration, 
congenital erythropoietic porphyria, and amelogenesis imperfecta. Discoloration due to 
tetracycline can occur in both dentitions, and the hue, varying from grey to brown, depends on 
the dose and type of drug (Cheek & Heymann, 1999). Uneven discoloration occurs in 
congenital erythropoietic porphyria, a disease characterized by an inborn error of porphyrin 
metabolism (Bhavasar et al., 2011). In Vitamin D-dependent rickets, clinical signs include a 
yellow-brown discoloration radiographically confirmable periodontal disease, large pulp 
chambers, and short roots. Vitamin D-resistant rickets is characterized by attrition and 
abscesses around non-carious teeth (Goodman et al., 1998). DGI features also occur in Ehlers-
Danlos syndrome, Schimke immune-osseous dysplasia, brachio-skeleto-genital syndrome, and 
Goldblatt syndrome (Barron et al., 2008) 
Prevalence of dentinogenesis imperfecta type II 
Information on the prevalence and incidence of DGI-II is scarce. The earliest investigation 
estimated an incidence of 0.0130.017% in a cohort of families in the state of Michigan in 
1957 (Witkop, 1957). Gupta et al. (2011) found that DGI was the rarest developmental dental 
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anomaly, presenting in 0.09% of the individuals in an Indian population. The prevalence of 
type II in a French population was estimated to be 0.057% (Cassia et al., 2017) and 0.1% in 
Saudi children (Yassin, 2016). The Indian, French, and Saudi Arabian studies were single 
center cohorts and had retrospective designs. Based on clinical experience, and the design of 
previous investigations, there is reason to believe that the prevalence of DGI-II is lower in 
Swedish children and adolescents.  
Osteogenesis imperfecta and dental aberrations  
Oral manifestations, with DGI being the most pronounced, are common findings in OI. Bone 
and dentin share many characteristics and are very similar in structure. Type I collagen is the 
main organic component in both tissues. A limited number of studies have investigated dental 
aberrations in OI. Aside from DGI, tooth agenesis, denticles, invaginations, taurodontism, and 
impacted permanent second molars have been found in OI (Bauze et al., 1975, Paterson et al., 
1983, Sunderland & Smith, 1980, Schwartz & Tsipouras, 1984, Lukinmaa et al., 1987b, Lund 
et al., 1998, O'Connell & Marini, 1999, Malmgren & Norgren, 2002, Saeves et al., 2009). 
Aberrant craniofacial development is another feature frequently seen in OI (Isshiki, 1966, 
Stenvik et al., 1985, Ormiston & Tideman, 1995, Jensen & Lund, 1997, Malmgren & Norgren, 
2002, Waltimo-Siren et al., 2005, Chang et al., 2007, Jabbour et al., 2018, Rizkallah et al., 
2013). 
 
Dentinogenesis imperfecta 
DGI was established as one of the cardinal signs of OI nearly 50 years ago (Witkop, 1971, 
Sillence et al., 1979). The Paterson et al. (1983) study allocated participants to a group without 
DGI (OI type IA) or a group presenting with DGI (OI type IB). DGI occurs more frequently in 
OI type III compared to the milder types (Lund et al., 1998, O'Connell & Marini, 1999, 
Malmgren & Norgren, 2002). In the early studies, information on the diagnostic criteria for 
DGI was scarce (Bauze et al., 1975, Paterson et al., 1983) (Table 4). It was later found that a 
diagnosis of DGI cannot be based on clinical signs only. Some individuals only present with 
radiographic and/or histologic findings (Lukinmaa et al., 1987a). Discolored teeth and 
histopathological findings in dentin sometimes occur in the absence of bulbous crowns, 
cervical constriction, and obliteration. Teeth from the same individual are almost identical, and 
intra-familial variability is low (Malmgren & Lindskog, 2003, Lukinmaa et al., 1987a). Nearly 
total accordance regarding DGI has been found between affected children and parents 
(Malmgren & Norgren, 2002). Presence of DGI has also been found to be more common in the 
deciduous dentition than the permanent (O'Connell & Marini, 1999, Malmgren & Norgren, 
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2002); it is not at all sure that a child with DGI in the deciduous dentition will develop DGI in 
the permanent dentition. Why this is so is not known.  
 
Table 4. Summary of prevalence studies on dentinogenesis imperfecta (DGI) in 
osteogenesis imperfecta (OI). 
 Type I Type III Type IV Total 
Study OI, n DGI, n  OI, n DGI, n  OI, n DGI, n OI, 
n 
DGI 
Bauze et al. (1975) 22 1 (5%) 17 7 (41%) 3 0 42 19% 
Paterson et al. 
(1983) 
166 29 - - - - 166 17% 
Paterson et al. 
(1983) 
69 41% - - 48 69%   
Schwartz & 
Tsipouras (1984) 
20 8 (40%) 7 4 (43%) 1 1 (100%) 28 43% 
Lukinmaa (1987) 45 4 (9%) 2 1 (50%) 16 13 (81%) 68 32% 
Lund et al. (1998) 50 4 (8%) 16 13 (81%) 22 8 (37%) 88 28% 
O´Connell & 
Marini (1999) 
-  22 18 (82%) 18 11 (61%) 40 73% 
Malmgren & 
Norgren (2002) 
36 10 (28%) 15 10 (67%) 14 7 (50%) 65 42% 
Saeves et al. (2009) 74 7 (10%) 8  8 (100%) 12 2 (17%) 94 19% 
 
 
Tooth agenesis 
Tooth agenesis denotes congenital absence of one or more teeth. It is one of the most common 
developmental orofacial birth defects. Hypodontia is defined as < 6 missing tooth germs 
(excluding third molars), and oligodontia as agenesis of ≥ 6 permanent teeth. Anodontia is the 
complete lack of tooth development in the deciduous and permanent dentitions (Phan et al., 
2016). Tooth agenesis has been found in individuals with OI (Lukinmaa et al., 1987b, 
Malmgren & Norgren, 2002). In the Lukinmaa et al. study, most patients were diagnosed with 
hypodontia. Seven of the nine lacked only one permanent tooth, and the others lacked several 
teeth. The prevalence of hypodontia was 18.4% in this cohort. No data regarding type of 
missing tooth germs were presented. Malmgren and Norgren (2002) found a similar frequency 
of tooth agenesis, 22%. 
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Taurodontism 
Taurodontism is defined by a lack of cervical constriction at the level of the cemento-enamel 
junction (CEJ), an enlarged pulp chamber, and apical displacement of the pulpal floor 
(Jafarzadeh et al., 2008). Taurodontism is a rare finding in the general population, where it 
occurs in 0.32.5% (Backman & Wahlin, 2001, Gupta et al., 2011). Presence of taurodontism 
has been identified in OI. Lukinmaa et al. (1987) diagnosed the trait in 6% of their investigated 
individuals. A later study found a higher prevalence, 42%, among individuals with OI type I 
and IV, but not in OI type III (Malmgren & Norgren, 2002). The etiology of the condition is 
not fully elucidated. Five causes have been proposed: (1) a specialized or retrograde 
characteristic, (2) a primitive pattern, (3) a Mendelian recessive trait, (4) an atavistic feature, 
and (5) a mutation resulting from odontoblastic deficiency during dentinogenesis of the roots. 
Hamner et al. suggested that Hertwig’s epithelial root sheath (HERS) explained the 
morphology that is characteristic for taurodontism (Hamner et al., 1964). 
Retention of permanent second molars 
Retention of permanent second molars is an unusual finding in healthy individuals, for 
example, Bondemark and Tsiopa (2007) observed retention in only 0.6% of healthy adolescents 
(Bondemark & Tsiopa, 2007). However, impaction of second permanent molars, 
predominantly in the upper jaw, was found in one study in 37% of individuals with OI 
(Malmgren & Norgren, 2002).  
Tooth eruption failure is primarily of two types: (1) Impaction, where retention is due to the 
ectopic position of the tooth germ or to an obstacle in the eruption path, and (2) Primary 
retention, where cessation of eruption is not caused by a physical obstacle in the eruption path 
or by the ectopic position of the tooth germ (Raghoebar et al., 1991). The etiology of permanent 
second molar retention includes aberrant craniofacial development, systemic disease, 
crowding, and disturbances of the PDL and nerve supply. Heredity may also contribute 
(Magnusson & Kjellberg, 2009).  
Malocclusion 
A common feature in OI is abnormal craniofacial development, which includes Class III 
malocclusions, anterior and posterior crossbites, and open bites (Jensen & Lund, 1997, 
Malmgren & Norgren, 2002, Waltimo-Siren et al., 2005, Chang et al., 2007, Rizkallah et al., 
2013). Inhibition of maxillary growth, maxillary hypoplasia in the anteroposterior and vertical 
dimensions, and mandibular protrusion and hyperplasia are all possible explanations of the 
frequently occurring Class III malocclusions (Isshiki, 1966, Stenvik et al., 1985, Ormiston & 
Tideman, 1995). 
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Genotype-phenotype correlation 
Few earlier studies have evaluated dental genotype-phenotype associations. The most relevant 
ones emphasized presence of DGI (Wenstrup et al., 1990, Jensen & Lund, 1997, Lund et al., 
1998, Luder et al., 1996, Rauch et al., 2010, Lindahl et al., 2015) and craniofacial development 
including malocclusion (Jensen & Lund, 1997, Jabbour et al., 2018). Lund et al. (1998) was 
the first study to evaluate a larger cohort. DGI is significantly more common in individuals 
presenting with mutations inducing a qualitatively changed collagen type I (Wenstrup et al., 
1990, Lund et al., 1998, Luder et al., 1996, Rauch et al., 2010, Lindahl et al., 2015).  
In addition, Lund et al. proposed that DGI could be a marker of structurally abnormal type I 
collagen (Lund et al., 1998). This research group also found that 55% of the individuals with 
mutations in the collagen α1(I) chain had DGI, whereas the corresponding figure was 80% 
among those with an α2(I) mutation. The Luder et al. case report (1996) examined an extracted 
permanent canine from a patient with OI type III and a mutation in COL1A2. The clinical and 
radiographic findings of the primary teeth agreed with DGI. The histological appearance of the 
permanent teeth revealed mild aberrations while the OI type was severe. It was hypothesized 
that odontoblasts could compensate for the genetic defect by excluding α2(I) chains and 
forming α1(I) homotrimer chains (Luder et al., 1996). Later studies revealed that the position 
is important for the presence of DGI, where DGI is more common in individuals harboring 
mutations in the C-terminal portion of the α chains (Rauch et al., 2010, Lindahl et al., 2015). 
In the Lindahl et al. study, a DGI diagnosis was based solely on primarily clinical findings, 
while the Rauch et al. study presented no information on how the diagnosis was made or if the 
deciduous, permanent, or both dentitions were examined.  
Genetic data of individuals with OI presenting with oral manifestations has been scarce in the 
literature. As DGI type I and the other dental aberrations have the most varying phenotypic 
expressivity, further evaluation of the dental aberrations in relation to the characteristics of the 
mutation is necessary. Greater understanding would increase our ability to better predict the 
severity and progress of the disease. Furthermore, this knowledge could improve our options 
to individualize dental treatment of children and adolescents with OI as genetic analysis may 
be a helpful aid in identifying individuals with an increased risk of oral complications.  
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AIMS OF THE THESIS 
General aim 
The general aim of the present thesis was to study the breadth of the spectrum of oral 
manifestations in a large cohort of children and adolescents with OI and relate it to genetic 
findings to enable better identification of individuals presenting with risk of severe oral 
manifestations. A further aim was to investigate the prevalence of DGI type II in Swedish 
children and adolescents, in order to map the extent of this rare disease in Sweden. 
Specific aims 
Study I 
To test the hypothesis that the prevalence of DGI type II is significantly lower than previously 
reported among Swedish children and adolescents and that there are undiagnosed cases of OI 
in individuals who were incorrectly diagnosed with DGI type II. 
Study II 
To test the hypothesis that congenitally missing teeth are more prevalent in individuals 
presenting with a mutation in COL1A1 and COL1A2 that is predicted to cause a qualitatively 
defect collagen type I and is related to type of OI and presence of DGI. 
Study III 
To test the hypothesis that presence of DGI in both dentitions, taurodontism, and retention of 
permanent second molars are more prevalent in children and adolescents with mutations 
predicted to induce qualitative defects of collagen type I. 
Study IV 
To test the hypothesis that individuals with OI, oligodontia, and severe hypodontia also 
presented with variants in other genes related to tooth development; that is, that these 
individuals presented with variants in modifying genes related to both COL1A1/COL1A2 and 
tooth development. 
  
  29 
SUBJECTS AND METHODS   
Subjects 
All cohort individuals in studies II, III, and IV received care from the Swedish national 
multidisciplinary pediatric OI team at Astrid Lindgren Children’s Hospital at Karolinska 
University Hospital in Stockholm. Today the team has several specialists involved in the 
assessment and care of children and adolescents with OI. The specialists represent the 
following fields: neurology, orthopedic surgery, genetics, radiology, orthopedic engineering, 
physiotherapy, occupational therapy, pediatric nursing, nursing, and pediatric dentistry. The 
team has assessed more than 90% of all Swedish children and adolescents with OI. All children 
seen by the team receive an individualized assessment. The pediatric OI team collaborates 
closely with local medical, dental, and habilitation teams. 
Since its formation in 1991, the pediatric dentists on the team have assessed 263 individuals. 
Of those, 179 were asked between 2006 and 2014 to participate in studies on genotype-
phenotype correlations in OI. The individuals in Studies II, III, and IV all come from this 
cohort. Studies II and III were a continuation of a previous study (Lindahl et al., 2015) and 
focused on oral manifestations of OI (Fig. 6). 
Study I 
At the 2013 Swedish Academy of Pediatric Dentistry meeting, we informed all pediatric dental 
specialists and dentists in Sweden of the planned study, and when we initiated it in 2014, invited 
them (n=179) to participate (all public and private specialist pediatric dental clinics [n=47] in 
all Swedish counties [n=21]). We asked for reports on all children and adolescents (0.119 
years old) who had been diagnosed with DGI-II and who were or previously had been in 
treatment. During 20142017, we continuously followed up all cases in order to confirm all 
children and adolescents presenting with DGI-II. 
Study II 
We evaluated 128 children and adolescents with OI (n = 128; boys = 74, girls = 54). Only one 
member from each family (the member with the most complete data and aged ≥ 7 years, when 
all permanent tooth germs could be evaluated) were accepted. We retrieved clinical 
characteristics from the medical and dental records, including information on the deciduous 
dentition and type of OI according to Sillence et al. (1979). OI type I was present in 81 
individuals, type III in 17, and type IV in 30.  
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Figure 6. Flow chart illustrating the study cohort of children and adolescents with OI whom 
OI team pediatric dentists evaluated regularly during 19912017. All 179 invited individuals 
consented to participate in genotype-phenotype investigations.  
 
Study III 
Study III recruited children and adolescents with OI from the same cohort as Study II. To avoid 
skewing the genetic impact of each mutation, this study also included only one child per family, 
the child with the most complete clinical data. In contrast to Study I, this study had no inclusion 
criterion for age. Any family history of DGI was noted. Children with no erupted teeth were 
excluded. The final study group comprised 152 individuals, 67 females and 85 males, of whom 
63% (96) were classified as OI type I, 15% (22) as OI type III, and 22% (34) as OI type IV.  
Study IV 
This study cohort included 11 children and adolescents with OI who had participated in a 
previous study (Malmgren et al., 2017): 7 presenting with oligodontia; 2 presenting with 
hypodontia; 1 with OI type IV who had the same variant in COL1A1 as another participant 
with oligodontia; and a participant from this previous study who had OI type IV but who was 
newly diagnosed with oligodontia. We evaluated the cohort further genetically. Three 
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participants were classified as OI type I, four as OI type III, and four as OI type IV. To allow 
evaluation of all permanent teeth, one inclusion criterion was age ≥ 7 years. 
Ethical permission 
The Swedish regional ethics committees in Stockholm and Uppsala approved the study 
protocols (Daybook no. 157/99, 2014/254-31, 2012/2106-31/4, and Ups 2006/212. Recruited 
participants and/or their legal guardians signed informed-consent forms. 
Clinical and radiographic examinations (I) 
At the start of this study, we contacted all public and private pediatric dental clinics in Sweden 
and requested all children and adolescents who had been diagnosed with DGI-II at the clinics 
and who were or previously had been in treatment. We asked the practitioners to examine the 
individuals and document the presence of DGI with photographs. Furthermore, we asked for 
available radiographs, to enable confirmation of DGI. 
Using the structured questionnaire and examination protocol that we sent them, the pediatric 
dentists interviewed and examined all patients with DGI-II regarding medical aspects such as 
bruising, prolonged bleeding, spraining, fractures, hearing impairment, and family history of 
osteoporosis and OI. The hue of the sclerae, the whites of the eyes, was assessed. The examiners 
used the Beighton scale to evaluate joint hypermobility; the hypermobility score ranged from 
0 to 9. The examiner explained and demonstrated each maneuver before asking the patient to 
attempt it.  
The clinical and, when indicated, panoramic radiographic examinations assessed dental 
variables associated with OI. Clinically, the following signs were evaluated: retained teeth 
(failure to erupt), malocclusion, and DGI (as defined by pathologic discoloration, attrition, and 
fractures). Radiographically, we assessed number of tooth germs, extended pulp chambers 
(taurodontism), and DGI indicators (bulbous crowns with cervical constriction, pulpal 
obliteration, and short roots). Individuals with suspected OI were referred to the OI pediatric 
team at Astrid Lindgren Children’s Hospital for further examination.  
Clinical and radiographic examinations (II, IV) 
All dental examinations were performed at Astrid Lindgren Children’s Hospital, Eastman 
Institute, or Karolinska Institutet in Stockholm. Clinical characteristics were collected from 
medical and dental records, including information regarding the deciduous dentition and the 
type of OI according to Sillence et al. (1979). Panoramic radiographs were analyzed regarding 
DGI and number of permanent teeth and tooth germs. The radiographic evaluation of DGI 
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included recording abnormalities in crown shape, cervical constrictions, and abnormally large 
or calcified pulp chambers. In cases of dental agenesis, a detailed family history was made.  
Clinical and radiographic examinations (III) 
Dentinogenesis imperfecta 
We examined the participants clinically if they had not been previously examined at Astrid 
Lindgren children’s hospital, Eastman Dental Institute or Karolinska Institutet. Signs of DGI 
were noted in the patient history during the clinical examination. Characteristic grey-blue or 
yellow-brown discoloration of deciduous or permanent tooth crowns solely or in combination 
with pathological attrition and/or fractures were regarded as clinical signs of DGI. Photographs 
were made to aid in further evaluation.  
All available radiographs, were evaluated for signs of DGI: abnormalities in crown shape, 
cervical constrictions, and abnormally large or calcified pulp chambers. We based our 
diagnosis of DGI on the combined clinical, radiographic, and histological findings. Two 
authors (KA and BM) evaluated all individuals retrospectively to document the development 
of the dental phenotype. 
Taurodontism 
We assessed the lower first permanent molars for signs of taurodontism. The degree of the 
relative amount of apical displacement was based on the size of the pulp chamber and the size 
and shape of the roots (Shaw, 1928) (Fig. 7). As taurodontism cannot be assessed in teeth 
exhibiting radiographic DGI characteristics, we excluded individuals with DGI from further 
evaluation of taurodontism.  
Retention of permanent second molars 
We assessed permanent second molars as retained based on radiographic signs and clinical 
findings, or absence of eruption at age 15 years. Inclination of retained second molars was 
assessed as mesioangular, vertical, or distoangular. 
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Figure 7. Classification of taurodontism: (a) cynodont = morphologically normal molar, (b) 
hypotaurodont = moderate enlargement of the pulp chamber, (c) mesotaurodont = extensive 
enlargement of the pulp chamber with shorter, but still separated roots, and (d) 
hypertaurodont = severe form, where the pulp chamber almost reaches the apex before it 
exits into 2 or 4 channels (Shaw 1928).    
 
We used lateral cephalometric radiographs to relate retention of permanent second molars to 
the craniofacial position of the jaws, type of OI, presence or absence of DGI, and type of 
mutation. Facad® software for orthodontic tracing and cephalometric analysis (ILEXIS AB, 
Linköping, Sweden) analyzed the lateral cephalograms. The positions of the maxilla and 
mandible were compared to normative cephalometric data for a Swedish population matched 
according to age, gender, and normal occlusion (Thilander et al., 2005). The sellanasionA 
point (SNA) angle was used to determine the position of the maxilla in the anterior-posterior 
direction, and the SN/SpPm angle to evaluate the position of the maxilla in the vertical 
direction. The sellanasionB point (SNB) angle was used to determine the anterior-posterior 
position of the mandible. We determined the inclination of the mandible by plotting the angle 
between the mandibular line (ML) and the SN line. We also measured the inclination of the 
upper and lower incisors based on the long axis of the teeth by their relation to the SN line and 
the ML (Fig. 8). 
Clinical and radiographic examination (IV) 
All participants underwent a detailed clinical and radiographic evaluation regarding total 
number of permanent tooth germs and teeth. In cases of dental agenesis, a family history was 
taken. The clinical examination included recording signs of DGI. 
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Figure 8. Skeletal reference points, lines, and angles evaluated. Reference points: S: 
The center of sella turcica, N: Nasion, Sp: Spina, the apex of the anterior nasal spine, 
Pm: Pterygomaxillare, A: The most concave point of anterior maxilla, B: The most 
concave point on the mandibular symphysis, Gn: Gnathion, the lowest point in the 
lower border of the mandible in the median plane, Go: Gonion, the most posterior 
inferior point on angle of the mandible. Reference lines: SN, SpPm (NL), ML: The 
mandibular line. Reference angles: SNA, SNB, SN/SpPm, SN/ML.  
 
DNA samples (II, III) 
Venous blood samples were taken and analyzed at Uppsala University Laboratory. DNA was 
extracted from peripheral blood, and all exon-intron boundaries of the collagen type I genes, 
COL1A1 and COL1A2 were amplified using standard protocols and primers. Sanger 
sequencing of DNA was done. Identified variants were confirmed by resequencing the affected 
exon, and when necessary, a segregation analysis in family members was done.  
DNA samples (IV) 
Venous blood samples were collected from all individuals. Genomic DNA was isolated at the 
Clinical Genetics Unit of Karolinska University Hospital. 
DNA isolation (II, III) 
Leucocyte DNA was isolated from peripheral blood using the Wizard® Genomic DNA 
Purification Kit (Promega) per manufacturer instructions. The GeneElute™ Mammalian 
Genomic DNA miniprep Kit (Sigma) was used to isolate DNA from bone and peripheral blood 
from infants. DNA concentration was determined with the Nanodrop ND-1000 (NanoDrop 
Technologies, USA). 
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Polymerase chain reaction and DNA sequencing (II, III) 
Polymerase chain reaction (PCR) primers were designed to cover the exon and flanking introns 
of the COL1A1 and COL1A2 genes and then carried out on a GeneAmp PCR system 9800 
using AmpliTaq® Gold kits and standard reagents. An adjusted Big Dye Terminator 3.1 
sequencing protocol was used for the sequencing reactions. The products were run on a 16-
capillary ABI 3130xl Genetic Analyzer automated sequencer and analyzed with Seqscapre 
v.2.5. Applied Biosystems, CA, USA (www.appliedbiosystems.com) supplied all reagents, 
equipment, and software. 
Multiplex ligation-dependent probe amplification (II, III) 
Individuals found to be negative for mutations after Sanger sequencing underwent multiplex 
ligation-dependent probe amplification (MLPA) analysis of COL1A1 and COL1A2 in order to 
detect large deletions and insertions. We used SALSA-MLPA Kits P271 COL1A1 and P272 
COL1A2 (MRC-Holland, Holland) per manufacturer instructions (www.mlpa.com).  
PCR and Sanger sequencing (IV) 
PCR and Sanger sequencing were performed to validate variants of interest and for segregation 
analysis. 100 ng of genomic DNA was mixed with 2.5 microliter of 10X PCR Buffer without 
MgCl2, 1.5 mM MgCl2, 0.2 mM dNTP, 0.2 µmolar forward and reverse primer and 2U of 
PlatinumTM Taq DNA Polymerase (Invitrogen). The reaction was incubated at 95C for 2 
minutes and followed by 35 cycles at 95C for 30 seconds, 59C for 30 seconds, and 72C for 
60 seconds. A final incubation of 2 minutes at 72C was performed. PCR products were run 
on 2% agarose gel and then cleaned up for cycle sequencing using illustra ExoProStar 1-Step 
(GE Healthcare Life Sciences). Cycle sequencing reactions were done using with BigDye 
Terminator v3.1 (Applied Biosystems) and M13 primers. After ethanol precipitation to clean 
up unbound ddNTPs, fragments were sequenced in the ABI 3730XL Genetic Analyzer 
(Applied Biosystems). Primers for exon 6 of AXIN2 are available upon request. 
Whole-genome sequencing and bioinformatics analysis (IV) 
Libraries were prepared for sequencing on Illumina HiSeqX (Illumina Inc, San Diego, CA, 
USA) from the genomic DNA using the Illumina TruSeq DNA PCR-Free kit with a mean insert 
size of 400 bp. An in-house pipeline developed by the Science for Life Laboratory, Stockholm, 
Sweden was used to map reads to the human reference genome (hg19) and to call variants. 
Data were aligned to the reference genome using bwa (v0.7.12).  
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We deduplicated, recalibrated, and indel realigned raw alignments using GATK (v3.3-0-
geee94ec). The quality control information was gathered using Qualimap (v2.2) and single 
nucleotide variants (SNVs) and indels were called using the HaplotypeCaller in GATK. We 
further processed the variants with GenotypeGVCFs, VariantRecalibrator, 
ApplyRecalibration, VariantFiltration and SelectVariants tools in GATK (v3.7); the variants 
were then functionally annotated using the Variant Effect Predictor (VEP; version 89) and 
loaded into a database using GEMINI (v0.20.0). Two approaches were followed. In the first 
approach, we excluded variants with minor allele frequencies of 0.1% and higher in the 1000 
Genomes Project (1000G), the 6500 NHLBI-GO Exome Sequencing Project (ESP), the 
Swedish Genome Project (SweGen), and the Exome and Genome Aggregation Consortium 
(ExAC and gnomAD). In the second approach, we focused only on genes involved in human 
nonsyndromic and syndromic hypodontia/oligodontia and tooth development in animal 
models. Here, we applied a minor allele frequency higher than 1% for the listed genome 
projects to filter out common variants. In both approaches, variants located in repetitive 
sequence regions were excluded. Only non-synonymous variants, frameshift indels and 
putative splice site variants were considered for further analysis. We used Combined 
Annotation Dependent Depletion (CADD) to score the pathogenicity of the SNVs. The 
evolutionary conservation of variants was evaluated with Genomic Evolutionary Rate Profiling 
(GERP). The variants were explored in the database using built-in tools in GEMINI and were 
visualized on Integrated Genome Viewer (IGV).  
Structural variants were analyzed using the FindSV pipeline 
(https://github.com/J35P312/FindSV), which merges calls from CNVnator V0.3.2 and 
TIDDIT. The structural variants were annotated using the VEP and filtered based on the quality 
flag of the variant. The filtered and annotated variants were then sorted based on a local 
structural variant frequency database consisting of variants from 1000 healthy individuals in 
the SweGen project. The reads at breakpoints were visualized in the IGV. The structural 
variants that fell into intergenic regions as well as intronic deletions and duplications were 
excluded. We focused only on breakpoints that were located in the exons of the coding genes 
listed in our gene list.   
Nomenclature (II, III, IV) 
We followed the recommendations of the Nomenclature Committee of the Human Genome 
Variation Society (www.HGVS.org/varnomen) to describe sequence variations and used the 
GenBank reference sequences of COL1A1 (genomic DNA NG_007400.1 and cDNA 
NM_000088.3) and COL1A2 (genomic DNA NG_007405.1 and cDNA NM_000089.3).  
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Collagen type I mutations were reported to the osteogenesis imperfecta & Ehlers-Danlos 
syndrome variant database (http://www.le.ac.uk/genetics/collagen/) (Dalgleish, 1997, 
Dalgleish, 1998). Study IV used the most recent GenBank reference sequences for the 
relevant gene to describe the variants. 
Statistical analyses 
All statistical analyses in Study II were done using Statistica v. 12.5 (Statsoft, Scandinavia AB, 
Uppsala Sweden). The statistical analyses in Studies I, III, and IV were done using the 
Statistical Package for the Social Sciences (SPSS for Windows, v. 24 and v.25; IBM SPSS 
Inc., Chicago, IL, USA). 
Study I 
Prevalence was calculated as the ratio of the number of individuals with DGI to the number of 
individuals born between 1996 and 2015 in Sweden. Cumulative incidence was calculated as 
the ratio of the number of new cases of DGI reported during 19962015 to the number of 
newborns at risk of DGI during that time period. Incidence rate per unit of time was calculated 
as the ratio of the number of new cases to the number of persons at risk of developing DGI. 
Data were summarized as proportions, or counts, or means and standard deviations. For 
categorical variables, the X2 test determined differences in frequencies of dental aberrations. 
The independent t-test evaluated continuous variables. Two-tailed p-values were computed 
using p < 0.05 to denote a significant deviation from the null hypothesis. 
Studies II and III 
We used Fischer’s exact test (X2 test) to evaluate categorical variables and determine 
differences in frequencies of tooth agenesis, presence of DGI, taurodontism, retention of 
permanent second molars, malocclusion, quantitative/qualitative collagen I defects, genes 
(COL1A1 vs. COL1A2), gender, and type of OI. Two-tailed p-values were used, and p < 0.05 
denoted a significant deviation from the null hypothesis. The independent t-test was used for 
evaluation of continuous variables.  
We chose age- and gender-matched controls to assess deviations in the cephalometric 
measurements of individuals with OI. Differences were calculated using this formula: Dev = 
(Xi-?̅? /sd) where Dev = difference, Xi = actual value, 𝑋 ̅= average value of the normal material, 
and sd = standard deviation of the reference material. The Mann-Whitney U test assessed 
differences between permanent second molar retention, DGI, cephalometric values, and 
Pamidronate treatment. 
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Study IV 
SPSS for Windows, v.25; IBM SPSS Inc., Chicago, IL, USA) was used for calculations of age. 
Otherwise statistical analyses were not applicable. 
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RESULTS  
Point prevalence, cumulative incidence, and incidence rate of 
DGI-II (I) 
The response rate concerning known cases was 100%; all clinics contacted us. Twelve 
counties reported cases of resident children diagnosed with DGI-II: 44 children and adolescents 
(19 males, 25 females) born between 1996 and 2015. During this period, there were 2,044,530 
births in Sweden (Socialstyrelsen, 2017). The 2015 point prevalence was thus estimated as 
0.0022% (95% CI, 0.00160.0029%; 2.2 in 100,000 individuals or 1 in 45,455 individuals). 
The incidence proportion/cumulative incidence of DGI-II was 0.0022% (2.2 per 100,000 
newborns per 20 years) in Sweden; the incidence rate was 0.00011% (95% CI, 
0.0000760.00014%) per person-year or 1.1 individuals per 1,000,000 person-years of 
observation/risk.  
Dental aberrations in children and adolescents with DGI-II  
Thirty individuals were clinically assessed according to the examination protocol. The 
remaining cases (n=14) were diagnosed based on personal communication with the responsible 
practitioner due to the patient wishing to be excluded from further participation or inability to 
attend the examination.  
Dental agenesis (hypodontia) was found in 9% of the children and adolescents with DGI-II. 
Tooth impaction/retention was diagnosed in 17% and pulpal obliteration was detected in all 
individuals for whom a radiographic examination was available (n=24).  
Presence of variables associated with OI in individuals presenting 
with DGI  
Variables associated with OI could be evaluated in the majority of the examined individuals. 
Eight subjects (25%, 6 boys and 2 girls) stated that they often had bruises and bruised easily. 
One individual (3%) reported a history of prolonged bleeding. Two individuals (6%) had 
experience of spraining. One 13-year-old girl reported a previous radius fracture (3%). The 
fracture was assessed as unassociated with OI as it had occurred after falling off a swing. One 
individual reported hearing impairment (3%) and one examined individual was found to have 
a scleral hue deviating toward blue or blue-grey tones (3%). Signs of joint hypermobility were 
found in 50% of the subjects who consented to be examined: 44% (7/16) boys and 56% (9/16) 
 40 
girls. The 30 examined individuals had a mean Beighton hypermobility score of 1.6 ± 2.1 
(range 06).  
Referral for further medical evaluation of OI  
Clinical and radiographic findings in one individual, a 2-year-old boy, gave rise to a suspicion 
of undiagnosed OI. The boy was referred to the national OI multidisciplinary pediatric team at 
Astrid Lindgren Children’s Hospital at Karolinska University Hospital; examination confirmed 
an OI diagnosis for the boy and suspected OI in the mother. 
Tooth agenesis related to mutations in COL1A1 and COL1A2 (II) 
Variants in COL1A1 and COL1A2 were identified in 104 of the 128 investigated individuals 
(103 by Sanger sequencing and 1 by MLPA). Of these mutations, 43% were predicted to induce 
a quantitatively changed collagen type I while 57% were predicted to cause a qualitatively 
changed protein. A large deletion of COL1A2 involving exon 118 was detected by MLPA in 
1 female. No variant in the collagen type I genes could be identified in 24 individuals (10 in OI 
type I (12%), 3 in OI type III (18%), and 11 in OI type IV (37%).  
The mean age at time of clinical evaluation was 13.8±4.3 years. The radiographic examination 
revealed tooth agenesis in 22 of 128 individuals (17%). Of those, 11% presented with 
hypodontia and 6% with oligodontia. Permanent premolars were the most frequent congenitally 
missing teeth (91%). No individuals exhibited tooth agenesis in the deciduous dentition. We 
detected pathogenic variants in COL1A1 or COL1A2 in 16 of 22 individuals presenting with 
tooth agenesis. All detected variants were located within the triple-helical domain of the 
molecules with no correlation between amino acid position and number of missing teeth. The 
prevalence of glycine to serine substitutions was similar among the patients with agenesis 
compared with the entire cohort. Tooth agenesis was more common in individuals with DGI 
(p=0.016) (Fig. 9) and in those harboring mutations predicted to cause a qualitatively changed 
protein (13/59, 22%) compared to those with quantitative defects (3/45, 7%), but this difference 
was not significant. Tooth agenesis was more common in individuals with OI type III (47%), 
compared with children with types I (12%, p=0.003) and IV (13%, p=0.017).  
Oligodontia was found in eight individuals. Six of these (75%) presented with mutations 
predicted to cause qualitative defects. In these individuals, gender, presence of DGI, and type 
of OI were equally distributed. We detected the same COL1A1 variant, p.(Gly821Ser), 
c.2461G>A, in two unrelated boys with OI type IV. One with a de novo mutation presented 
with eight teeth missing and no DGI. The other boy had no tooth agenesis, but he did have 
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DGI, as did his father. Another variant in COL1A1, p.(Gly1040Ser), c.3118G>A was identified 
in two other unrelated individuals (a girl and a boy). The girl had seven missing permanent 
teeth, while the boy had none missing. Both variants were de novo mutations, and neither 
individual exhibited signs of DGI. 
 
Figure 9. Distribution of tooth agenesis in relation to presence (n = 35) and absence (n = 93) 
of dentinogenesis imperfecta (DGI). 
 
Dentinogenesis imperfecta, taurodontism, and retention related to 
mutations in COL1A1 and COL1A2 (III) 
Mutations in COL1A1 and COL1A2 
We found COL1A1 and COL1A2 mutations in 81% of the individuals with OI (123/152; 121 
by Sanger sequencing and 2 by MLPA). Presence of DGI was seen in 70% of those with a 
predicted qualitatively changed protein compared to 27% in whom a quantitative defect had 
been found (p<0.001). 29% of the individuals (44/152) had a clinical and radiographic 
diagnosis of DGI and another 19% (29) only a histological diagnosis. In these 73 individuals, 
the prevalence of DGI was highest in children with OI type III and lowest in children with OI 
type I (86% vs. 31%; p<0.001). From clinical, radiological, and histological findings, we 
distinguished three main groups of patients with DGI: 1 = clear and distinct DGI in the 
deciduous dentition only, 2 = DGI in both dentitions, and 3 = DGI diagnosis possible only on 
histological examination. 
Presence of DGI in the deciduous dentition only 
Twenty individuals exhibited DGI in the deciduous dentition only. In most of these individuals, 
DGI was diagnosed clinically and radiographically with only subtle clinical signs in the 
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permanent dentition. These signs included slight discoloration of the mandibular incisors. In 
some cases, the diagnosis could be confirmed only by radiographic examination. 
Presence of DGI in both dentitions 
29% of the individuals for whom data on both dentitions were available had clear and distinct 
signs of DGI. Among group-2 individuals with COL1A1 mutations who had a glycine 
substitution C-terminal of p.Gly305, 70% (7/10) exhibited DGI in both dentitions compared to 
no group-2 individual (0/7) with a mutation N-terminal of this point (p=0.001). No individual 
with an N-terminal mutation exhibited clinical or radiographic signs of DGI in their deciduous 
teeth. In individuals with a glycine substitution located C-terminal of p.Gly211 in COL1A2, 
80% (8/10) exhibited DGI compared to no individual (0/5) presenting with a mutation N-
terminal of this point (p=0.007) (Fig. 10). None of the individuals with an N-terminal mutation 
exhibited any signs of DGI in their deciduous dentition. The congruence between presence of 
clinical DGI in the deciduous dentition and presence of DGI in the permanent dentition was 
high in all types of OI.  
 
Figure 10. Location of mutations in COL1A1 and COL1A2 in children and adolescents with 
dentinogenesis imperfecta in both dentitions. Distribution of missense mutations from N- to C-
terminal. Affected residues are numbered from translation initiation.  
 
Presence of isolated histological DGI 
In 54% of the individuals without clinical or radiographic signs of DGI, a diagnosis of DGI 
was confirmed histologically. The histological changes were milder compared to those of the 
patients with clinical and radiographic signs of DGI. No individual with isolated histological 
DGI in the deciduous dentition exhibited signs of DGI clinically or radiographically in the 
permanent dentition. 
Taurodontism 
Taurodontism occurred in 18% of individuals who could be evaluated for this condition. The 
difference in presence of taurodontism between individuals with quantitative (18%) and 
individuals with qualitative (13%) defects was not significant.  
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Retention of permanent second molars 
Of the study cohort, 31% exhibited retention of permanent second molars with 16% of these 
presenting with a quantitative defect and exhibiting retention compared to 50% of those 
presenting with a qualitative defect (p=0.003). Maxillary mesioangular retention was the most 
common inclination, 63%. Retention was more common in individuals with OI type III (69%) 
compared to the individuals with OI type I (19%) (p=0.001). Significantly larger values were 
found for the SN to SpPm angle for patients with retention in the upper jaw (p=0.017) and for 
those with retention in both jaws (p=0.003) compared to individuals in the reference 
population. Significantly lower values were found for the ML to SpPm angle for patients with 
retention in the upper jaw (p=0.044). No significant difference between individuals with OI 
and the reference population was found in the SpPm angle and ML. Presence of DGI or 
Pamidronate treatment had no significant effect on retention of permanent second molars.  
Other rare gene variants in children with OI, hypodontia, and 
oligodontia (IV) 
We detected a novel homozygous nonsense variant in CREB3L1, p.Tyr428*, c.1284C>A in 
one boy previously diagnosed with OI type III. Our patient presented with oligodontia and 
severe malocclusion including a mandibular overjet, unilateral open bite and bimaxillary 
crowding. However, no DGI could be detected clinically or radiographically. In the other cases, 
COL1A1 and COL1A2 were the only two common genes among all cohort individuals which 
carried a mutation. However, we found rare variants with unknown significance in several other 
genes related to tooth development. No significant differences in distribution of variants 
between individuals with oligodontia and severe hypodontia could be seen. 
Among the detected variants, a missense variant in AXIN2 (rs200883019; p.Thr511Met, 
c.1532C>T), segregating with tooth agenesis in an autosomal dominant manner, was identified 
in the family of a boy with OI type IV and oligodontia.  
 
GENERAL DISCUSSION 
OI is a complex connective tissue disorder with a wide spectrum of symptoms. Oral 
manifestations are common, rendering a need for correct diagnosis and restorative, 
prosthodontic and surgical treatment. The expressivity of DGI varies and setting a differential 
diagnosis between DGI-I and DGI-II is challenging. In this thesis, the aim was to map the 
extent of DGI-II in Swedish children and adolescents and to test the feasibility of differentiating 
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it from DGI-I in clinical dental practice. Furthermore, we aimed to elucidate the broad spectrum 
of dental and craniofacial manifestations in children and adolescents with OI related to genetic 
findings. We found a lower prevalence of DGI-II compared to previous studies. Collagen type 
I mutations that were predicted to induce a qualitatively changed protein product were 
associated with a higher prevalence of dental aberrations and malocclusion. 
 
Prevalence of DGI type II 
Prevalence studies serve many purposes. They are powerful tools for evaluating the extent of 
a disease in a specific population; thus, they are important for society and health services in the 
planning and allocation of resources needed to manage the condition. Comparison of disease 
prevalence between different areas within and between countries is also often important. 
Mapping occurrence of the disorder allows study of changes in severity and frequency over 
time. This thesis found an estimated prevalence for nonsyndromic DGI-II of 0.0022% (95% 
CI, 0.00160.0029%) or 2.2 affected in 100,000 individuals. This is significantly lower 
compared to previous studies reporting a prevalence between 0.0130.1% (Witkop, 1957, 
Gupta et al., 2011, Yassin, 2016, Cassia et al., 2017). 
The differences in frequencies clearly indicate the variance of this rare disease. We found a 
regional variation. This is not surprising as DGI-II is a disease inherited in an autosomal 
dominant manner with a low frequency of de novo mutations. Thus, individuals with DGI-II 
have a 50% chance of passing on the mutant gene and the disorder, to each of their children. 
Since it is likely that several individuals from the same family reside in the same area, the 
prevalence of this rare disease in that county would be significantly elevated. The loss of 
genetic variation that occurs in populations established from a small number of individuals and 
with a low degree of migration is substantially higher than in more heterogeneous populations 
with higher migration; the risk of pathogenic variants is thus higher in the former. Previous 
studies have been based on patient cohorts from one regional center, and the group of examined 
individuals may therefore not be representative for the country as a whole (Gupta et al., 2011, 
Yassin, 2016, Cassia et al., 2017).  
Methodological differences may also be important for variance. The diagnostic criteria are of 
utmost importance for correctly identifying individuals presenting with the disorder. It is 
always wise to clearly declare the diagnostic criteria used in order to simplify comparability 
with new investigations. In the present cohort, we observed a prevalence of hypodontia of 9%, 
which is only slightly higher than reported for the population in Nordic studies (Aasheim & 
Ogaard, 1993, Backman & Wahlin, 2001, Haavikko, 1971). Another finding in the present 
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study was tooth retention or impaction (third molars excluded) in 17%. Retention of permanent 
second molars is a frequent finding in OI (Lukinmaa et al., 1987b, Malmgren & Norgren, 
2002), but was not found in any individuals in this cohort of individuals with DGI-II. This 
indicates that retention of permanent second molars is more likely the result of the aberrant 
craniofacial development in OI than due to the bulbous crowns present in DGI.  
We evaluated several variables indicative for OI that can be used in clinical practice to 
differentiate individuals with DGI-I and DGI-II. Using a structured questionnaire and an 
examination protocol with guidelines, pediatric dentists interviewed and examined patients 
regarding aspects such as bruising, prolonged bleeding, spraining, fractures, hearing 
impairment, and a family history of osteoporosis and OI. The degree of joint hypermobility and 
hue of sclerae, the whites of the eyes, were also assessed. Based on these variables, we 
identified one individual, a 2-year-old boy with OI type IV whose diagnosis had been 
overlooked. Several individuals with DGI presented with one or a few of these symptoms. 
Referral for further medical evaluation of OI should be based on presence of several of these 
variables. It is reasonable to suggest that a history of fractures is the primary indicator that may 
raise suspicion. Clinical experience of assessing children with OI and DGI-I and DGI-II 
indicates that it is probably most relevant to first identify children with DGI and recommend 
further medical evaluation. The results show that it is possible to identify children with OI with 
this approach.  
Tooth agenesis in OI 
The frequency of hypodontia (11%) and oligodontia (6%) in the cohort of OI patients was high. 
Tooth agenesis has previously been reported in individuals with OI (Lukinmaa et al., 1987b, 
O'Connell & Marini, 1999). The Finnish study found 18% presenting with the trait compared 
with 10% in the O’Connell and Marini study.  
Because we wanted to evaluate the spectrum of the genetic impact on tooth agenesis in OI, we 
decided to include only one child per family, in contrast to previous studies. Furthermore, we 
only assessed individuals over the age of 7 when all permanent tooth germs have reached a 
developmental stage enabling radiographic evaluation. The teeth most often congenitally 
missing were permanent premolars (91% of the missing tooth germs), indicating that agenesis 
in the premolar regions is a specific feature in individuals with OI. Only four lateral incisors 
were missing. Agenesis of permanent lateral incisors and lower second premolars are equally 
distributed in the general population (Brook, 1974, Chosack et al., 1975). Oligodontia was 
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more common in individuals with a mutation predicted to induce a qualitatively changed 
protein product, but as an individual factor, this mutation did not explain the phenotype.  
We found an inter- and intrafamilial variability in the expression of tooth agenesis and DGI. 
The same variant in COL1A1 (p.(Gly821Ser), c.2461G>A) was detected in two unrelated males 
with OI type IV. One of these presented with a de novo mutation, eight congenitally missing 
teeth, and no DGI. The other boy exhibited DGI, but no tooth agenesis. These findings led us 
to evaluate the potential of modifying genes that could explain the phenotypic differences. 
We found that the boy with the variant in COL1A1 (p.(Gly821Ser), c.2461G>A) and 
oligodontia also presented with a variant in AXIN2 (p.Thr511Met, c.1532C>T). The proband’s 
mother, grandfather, and an aunt, all carriers of the variant, were unaffected by OI but presented 
with hypodontia. Interestingly, none of them could be diagnosed with oligodontia. This finding 
indicates that the more severe phenotype seen in our proband may be due to additive effects of 
the variants in COL1A1 and AXIN2 and their modifying or interacting genes.  
AXIN2 encodes the axis inhibition protein 2, a protein that facilitates β-catenin degradation by 
forming a destruction complex in the canonical Wnt signaling pathway. Wnt signaling plays a 
vital role in early tooth development (Chen et al., 2009) and is intense in the epithelial initiation 
centers and enamel knots (Liu et al., 2008, Ahtiainen et al., 2016). AXIN2 may act as a Wnt 
feedback inhibitor. Several mutations in AXIN2 have been associated with varying severities 
of hypodontia and oligodontia (Bergendal et al., 2011, Liu et al., 2015, Wong et al., 2014, Yue 
et al., 2016). The findings indicate that an increased Wnt/β-catenin signaling caused by altered 
function of AXIN2 may cause tooth agenesis.  
Our finding further indicates the possibility of parallel genetic events that may explain the 
expressed phenotype. Overlapping phenotypes may involve proteins that have close interaction 
at the molecular level or distantly at the level of the functional unit or organ system (Posey et 
al., 2017). Except for the variants we found in COL1A1, COL1A2, and CREB3L1, we were 
unable to identify any other mutual variant related to collagen type I that could explain the 
phenotype with OI and oligodontia. Based on our findings, we suggest that the cause of the 
expressed phenotype is the collagen I mutation, but that additive effects from rare variants in 
several other genes may be important.  
 
Expressivity of DGI in relation to genetic findings in OI 
The expressivity of DGI was varying and differed significantly between the deciduous and 
permanent dentitions. The deciduous teeth were always most severely affected. This finding is 
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in accordance with previous studies (O'Connell & Marini, 1999, Malmgren & Norgren, 2002). 
Presence of DGI in both dentitions was significantly more common in individuals with a 
mutation predicted to result in a qualitatively changed collagen type I. No significant difference 
between affected chains (α1 vs. α2) could be found. Phenotypic severity seemed to be gradient 
dependent. Substitutions of glycine residues for another amino acid in the triple helix were 
more severe when they occurred towards the carboxy-terminal end. We found that no 
individuals harboring mutations amino-terminal of p.Gly305 in COL1A1 and p.Gly211 in 
COL1A2 presented with DGI in both dentitions.  
Our findings are in accordance with the gradient model proposed by Byers et al. (1991). 
Assembly of the three α chains initiates in the C-terminal portion of the molecule and proceeds 
towards the N-terminal end (Marini et al., 2017). The C-terminal substitution of glycine by 
another amino acid may cause prolonged retention of the procollagen chain in the ER, resulting 
in longer exposure to posttranslational modifying enzymes (Ishikawa & Bachinger, 2013). 
Possibly, this causes a greater portion of retained and degraded intracellular procollagen in the 
odontoblasts, and more severe disturbance of protein secretion due to odontoblastic 
dysfunction. It has been hypothesized that mutated procollagen chains could be intracellularly 
retained within the ER and within transition and secretion vesicles. This would cause the 
odontoblasts to become dysfunctional (Hall et al., 2002). Such a response by the odontoblasts 
may be in accordance with studies of the ER stress response of osteoblasts and fibroblasts, 
where the intracellular retention of abnormal collagen chains cause apoptosis activation, 
autophagy stimulation, and impaired osteoblast stimulation (Ishida & Nagata, 2009, Forlino et 
al., 2007, Bianchi et al., 2012, Gioia et al., 2012). A previous study found intracellular retention 
of mutant procollagen in fibroblasts that resulted in a reduced amount of collagen type I in the 
ECM (Bateman et al., 1984). 
The next important step is the interaction between collagen type I and the ECM. When 
abnormal collagen is secreted into the matrix, the composition changes abruptly and interferes 
with mineralization. These abnormal chains assemble into abnormal fibrils, resulting in an 
aberrant ECM, indicating that the mutation plays a significant role in altering protein behavior 
on assembly. In study II, 54% of the patients without clinical or radiographic signs of DGI 
exhibited histologic findings of DGI. Interestingly, isolated DGI was more common in 
individuals with quantitative collagen I defects. The teeth exhibited less severe dentin 
manifestations. This finding indicates that the odontoblasts may also be affected in quantitative 
defects, but to a lesser extent. An interesting finding is that no individuals harboring a mutation 
causing a quantitatively changed protein exhibited any signs of DGI clinically or 
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radiographically. We thus suggest that presence of a qualitatively changed protein is mandatory 
for development of clinical and radiographic DGI. 
The higher prevalence of DGI in the deciduous than the permanent dentition remains to be 
elucidated. The time needed for the odontogenesis of the deciduous compared to the permanent 
dentition is short. It is reasonable to propose that the genetic program regulating the 
odontoblastic activity is in specific ways variable and that the influence of epigenetic factors is 
important for the expressed difference. Initiation of odontoblastic differentiation starts at the 
future cusp tips. Several genes important for odontoblast differentiation have been found, 
including WNT10A. WNT10A is highly expressed in the mesenchyme inducing the 
preodontoblasts to become functional DSPP-expressing odontoblasts (Yamashiro et al., 2007). 
Other genes of importance are e.g. BMP/TGFβ. The expression of these genes during 
development may have different effects on the ability of odontoblasts to perform 
dentinogenesis in a space- and time-specific manner (Lesot et al., 2001). 
Taurodontism 
Taurodontism was a frequent finding in this cohort. The prevalence of 18% found was high 
compared to the prevalence in the general population (Backman & Wahlin, 2001, Gupta et al., 
2011), but lower than in the Malmgren and Norgren study (Malmgren & Norgren, 2002), which 
reported a prevalence of 42%. We evaluated taurodontism only in mandibular permanent first 
molars, as this tooth was most reliably assessed based on radiographic projection. It is 
reasonable to expect that the frequency would have been higher if all permanent molars had 
been included. We found no correlation between taurodontism and any specific type of 
collagen I mutation (qualitatively or quantitatively changed protein). We hypothesize that our 
findings indicate the importance of collagen I as one of multiple components involved in the 
intricate epithelial-mesenchymal interactions in the morphologic development of permanent 
teeth. Understanding the mechanisms underlying these interactions remain to be elucidated. It 
has been suggested that the explanation to the characteristic morphology in taurodontism can 
be found in the HERS (Hamner et al., 1964). Root formation begins after the crown has been 
fully formed. During this process, the outer and inner dental epithelium fuse to form HERS. 
This process results in the differentiation start of the root odontoblasts. Taurodontism is a 
characteristic finding in tricho-dento-osseous syndrome (MIM 600525), caused by 
heterozygous mutations in the DLX3 gene. DLX3 is located on the same chromosome 
(17q21.33) and close to COL1A1. Furthermore, taurodontism has been observed in several 
other syndromes (Joseph, 2008, Axelsson, 2005, Islam et al., 2005, Jaspers, 1981). As HERS 
is induced before odontoblast differentiation, we suggest that it is more likely that earlier 
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aberrant collagen I expression in the mesenchyme may be important for epithelial-
mesenchymal interactions during tooth morphogenesis. Furthermore, based on previous 
findings, taurodontism appears to be a polygenic trait, and the collagen I disturbance may have 
direct and indirect interactional effects on related genes and their protein products. 
Retention of permanent second molars and craniofacial 
aberrations in OI  
We found a high prevalence of retained permanent second molars (31%). Mesioangular 
maxillary retention was most frequent. Impaction of permanent second molars is an uncommon 
finding in healthy individuals (02.3%) (Bondemark & Tsiopa, 2007, Farman et al., 1978, 
Varpio & Wellfelt, 1988). Physical obstacles, crowding, and failures in the eruption mechanism 
have been proposed etiological factors for retention of permanent second molars (Magnusson 
& Kjellberg, 2009). We found that retention was more common in individuals harboring a 
qualitatively changed collagen type I. Furthermore, aberrant craniofacial development was 
seen significantly more often in individuals presenting with molar retention compared to 
individuals with OI and no retention in comparison with age- and gender-matched controls. It 
has previously been hypothesized that the retention of permanent second molars is caused by 
the bulbous crown of the permanent first molar (O'Connell & Marini, 1999). However, 
retention was also seen in individuals not affected by DGI. This finding is in line with 
Malmgren and Norgren (2002). Based on our findings, we suggest that the primary etiology in 
OI is lack of space in the maxilla. Aberrant craniofacial development in OI with a retrognathic 
maxilla has been reported in previous studies (Jensen & Lund, 1997, Waltimo-Siren et al., 
2005). 
The highly complex nature of craniofacial morphogenesis suggests involvement of a 
substantial number of genes, but to date only a few loci have been identified. Development of 
the craniofacial complex is modulated by sophisticated and exactly timed gene expression 
mediated by complex signaling pathways (Carlson, 2015). It is not reasonable to suggest that 
the collagen type I mutation itself is enough to explain the expressed phenotype; genes do not 
act in a vacuum. Compared with in non-affected individuals, unlike responses to hormones, 
nutritional status, and biomechanical factors may affect facial morphogenesis (Williams & 
Slice, 2010). Nevertheless, mandibular prognathism, lateral open bite, crossbite, and retention 
of permanent second molars are frequent findings in OI. Thus, it is reasonable to suggest that 
collagen type I defects are important. The bones of the jaws form through intramembranous 
ossification. Increases in the size of these bones are mainly driven by surface apposition, where 
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sutures are found (Waltimo-Siren et al., 2005). Based on our findings, it can be speculated that 
the defect collagen type I results in a direct or indirect structural and physiological change at 
these locations.  
Methodological considerations 
This thesis has strengths and limitations. The prevalence of DGI-II and the medical variables 
associated with OI were evaluated. One strength is that we searched for cases in all Swedish 
counties. The prevalence calculations were based on official statistics from the National Board 
of Health and Welfare. We assessed these data as reliable because we assumed a coverage ratio 
of > 95%. A limitation is that not all individuals born during the years 19962015 were 
examined regarding DGI-II. Obviously, this would be an impossible task. However, all 
Swedish children and adolescents have regular dental examinations. It is less likely that 
individuals with DGI-II are undiagnosed because of the severe expression of the disease. 
Furthermore, it can also be assumed that the majority of children with DGI-II have been 
assessed at specialist pediatric dental clinics. Attempts were made to contact clinics that did 
not report cases for several years. Other possible limitations include the presence of several 
practitioners, which reduces interobserver reliability. 
The large cohort of children and adolescents with OI is the major strength of this study. New 
knowledge of rare diseases is mainly based on case reports. The possibility to retrospectively 
evaluate dental development of 152 children and adolescents with OI is a unique opportunity 
for increasing understanding of the distribution of dental and craniofacial disturbances in OI 
that clinicians treating these individuals should be aware of. Nevertheless, the retrospective 
design has limitations. One limitation is that observations were based on available data. This is 
clear due to the missing data for some variables. Prospective cohort studies provide a clear 
protocol for which variables should be documented and in what way.  
This is the first time whole-genome sequencing was used to specifically describe the dental 
phenotype in OI. The approach resulted in detection of a rare homozygous variant in CREB3L1 
in one child and several rare variants of uncertain clinical significance in genes related to tooth 
development. The approach opens up the possibility of further evaluating the effects of these 
genes. The difficulty of interpreting data from whole-genome sequencing and small sample 
size are other limitations. WGS provides us with a wealth of information that needs to be 
properly assessed. We must be able to discriminate potentially pathogenic variants from benign 
variants that explain normal human heterogeneity. We used a large number of databases and 
prediction algorithms to assess the detected variants regarding expected severity. However, one 
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limitation is that we did not confirm results of all detected variants or examined relatives via 
Sanger sequencing. Such an approach would further assist in the filtering process. Furthermore, 
functional validation would be important to assess the effect of the variant on the protein 
function level.  
Ethical considerations 
Several ethical questions should be considered. The handling of genetic information is a 
responsibility. Detection of a pathogenic variant in a proband means that relatives may be 
carriers and prospective children may inherit the variant. Nevertheless, genetic testing is of 
utmost importance when diagnosing rare diseases. A rare disease is a health condition that 
affects a small number of individuals compared with other prevalent diseases in the general 
population (Richter et al., 2015). OI is by definition a rare disease. The interpretation of genetic 
data is challenging. To ascertain that this could be done in an appropriate way, clinical 
geneticists and a bioinformatician were involved to ascertain test accuracy and interpretation 
of results, and to handle potential post-testing complications. Several factors are relevant to 
consider in the decision making of genetic tests; these include integrity, beneficence, non-
maleficence, and justice. However, several additional variables should be considered. 
Dilemmas arise when any of these variables cannot be satisfied. We need to ask ourselves: 
Who will obtain positive effects of the test? Is there anyone who may be harmed by the 
information? All factors need to be weighed in order to make an assessment. If the patient 
consents to testing, we must consider the individual’s right to know, but also the right not to 
know. Feedback of the obtained information must be handled in a reflective way. Results 
revealing a clinically relevant condition that can be treated during childhood should be reported 
to the legal guardians. The identification of pathogenic variants in COL1A1 and COL1A2, 
which cause OI, may be such an example. There is a great diagnostic value for the patient and 
clinician, where the benefits outweigh the risks as a diagnosis gives the opportunity to treat all 
aspects of the disease.  
Increasing our understanding of the full spectrum of symptoms by assessing many individuals 
with a rare disease is also important. Diagnostic delay is frequent in individuals with rare 
diseases. By assessing more individuals, it is possible to increase the understanding of the 
breadth of the symptoms. In the long run, this knowledge may increase the ability to correctly 
diagnose children with the disorder and identify medical and dental problems at an earlier stage. 
Because of the impact on the child’s physical and mental health, it is of value for the individual 
to obtain a correct diagnosis as early as possible. As we increase our understanding of the 
human genome and the variants seen in rare diseases, better and more sensitive diagnosis and 
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treatment become possible. It is our hope that these pieces in the jigsaw puzzle will be of value 
for our future ability to personalize medicine for treatment, and a potential cure. 
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MAIN FINDINGS AND CONCLUSIONS 
Prevalence of DGI-II in Swedish children and adolescents 
This thesis found a DGI-II prevalence of 0.0022% or 2.2 in 100,000 children and adolescents. 
Among the reported cases of DGI-II, we identified one child with undiagnosed OI.  
Tooth agenesis in OI related to mutations in the collagen type I 
genes and genes related to tooth development 
A high prevalence of tooth agenesis was seen in children and adolescents with OI. Collagen I 
mutations are associated with congenitally missing teeth and significantly more frequently seen 
in individuals with DGI, and in OI type III compared to type I or IV. Oligodontia is more 
common in individuals harboring collagen type I mutations predicted to cause a qualitative 
defective protein. We detected several rare variants of uncertain clinical significance, in genes 
associated with tooth development. Based on the findings in this thesis, we suggest that the 
cause of the expressed phenotype is the collagen I mutation, but that additive effects from rare 
variants in several other genes are important. 
Mutations in COL1A1 and COL1A2 and dental aberrations in 
children and adolescents with OI 
Our results indicate a higher risk of developing multiple dental aberrations including DGI, 
taurodontism, retention of permanent second molars, and craniofacial developmental 
disturbances in children and adolescents with OI. The presence of DGI, and retention of 
permanent second molars due to deviating craniofacial development is strongly associated with 
mutations predicted to cause a qualitatively changed protein. Collagen chain mutation position 
is correlated with the risk of developing DGI in both dentitions. Based on the findings in this 
thesis, taurodontism and retained permanent molars are clinical signs that support further 
clinical investigation to rule out a mild form of OI in an individual that is fracture prone. 
Finally, our results highlight the importance of carefully assessing and following children and 
adolescents with OI clinically, radiographically, and histologically over time in order to obtain 
correct diagnoses and identify potential oral complications at an earlier age. Genetic analysis 
can be helpful in identifying individuals with an increased risk of dental and craniofacial 
disturbances. 
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CLINICAL IMPLICATIONS AND CONSIDERATIONS IN OI 
OI is a disorder associated with a range of oral complications due to the mutations in COL1A1, 
COL1A2 and potentially genes involved in the transcription and posttranslational modification 
of type I collagen. The findings in this thesis highlight the complexity of the traits and the high 
inter- and intravariability in individuals harboring the different mutations.  
Diagnosis of DGI-II and differential diagnosis of DGI-I 
In this thesis we investigated the prevalence and incidence of DGI type II in Swedish children 
and adolescents. We further evaluated the presence of medical and dental variables associated 
with OI in these children. We detected one boy with previously undiagnosed OI. Our findings 
underscore the importance of evaluating OI symptoms in children and adolescents diagnosed 
with DGI-II. The protocol used in this study can be used for this purpose. The variables include 
questions regarding bruising, prolonged bleeding, spraining, fractures, hearing impairment, and 
family history of osteoporosis and OI. Assessment of joint hypermobility and sclerae may also 
be included in the examination. Clinical dental variables associated with OI include presence 
of retained permanent second molars, malocclusion, and DGI indicators – pathologic 
discoloration, attrition, and fractures. Radiographically, number of tooth germs, extended pulp 
chambers (taurodontism), and DGI indicators such as bulbous crowns with cervical 
constriction, pulpal obliteration, and short roots may be evaluated. Heredity of DGI is also an 
important indicator to consider for differential diagnosis as de novo mutations in the DSPP 
gene are uncommon. Our findings also indicate that DGI type II is less common compared to 
OI (2.2 per 100,0000 individuals compared to 7.4 per 100,000 individuals) (Lindahl et al., 
2015). 
Tooth agenesis 
OI is associated with an increased risk of hypodontia as well as oligodontia. Based on our 
findings, it is important to diagnose agenesis at an early stage. We suggest that a panoramic 
radiograph be made at 7 years of age in children and adolescents with OI. We detected 
oligodontia in all types of OI. This finding indicates that severe agenesis may also be found in 
an individual presenting with OI of mild severity. Furthermore, our findings indicate that the 
possibility of undiagnosed OI should be considered in individuals presenting with oligodontia 
and hypodontia. Further evaluation regarding presence of the above mentioned medical and 
dental variables associated with OI may be indicated in such an evaluation. If suspicion of OI 
remains, referral to a pediatrician is indicated. Highly specialized competence is available at 
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the Swedish national multidisciplinary pediatric OI team at Astrid Lindgren Children’s 
Hospital at Karolinska University Hospital for evaluation. 
Diagnosis of DGI-I 
We found that risk of developing DGI in both dentitions differed depending on the localization 
of mutations in the collagen type I chains. Our findings can be useful in clinical consultations 
to better answer questions from parents regarding whether their child presenting with DGI in 
the deciduous dentition also has an increased risk of an affected permanent dentition. Children 
with no DGI in the deciduous dentition and a mutation located on the N-terminal of p.Gly305 
in COL1A1 and p.Gly211 in COL1A2 did not develop DGI in the permanent dentition. The 
deciduous dentition is always the most severely affected. Those presenting with only subtle 
histological signs of DGI in the deciduous dentition did not develop clinical or radiographic 
signs of DGI in the permanent dentition. The high frequency of mutations that induce 
quantitative defects stress the importance of histologic analysis of exfoliated teeth also in 
mildly affected children and adolescents with OI.  
Taurodontism 
Taurodontism is a frequent finding in OI. Our findings indicate the importance of collagen type 
I as one of several components involved in the intricate epithelial-mesenchymal interactions in 
the morphologic development of permanent teeth. Children with OI and taurodontism only 
occasionally exhibited the more severe form of taurodontism. Subjective complaints are rare; 
however, presence of taurodontism can be challenging in cases that require endodontic 
treatment. The complicated variation of canal configuration and apical displacement of the 
orifices stress the importance of magnification for successful instrumentation and obturation.  
Retention of permanent second molars 
We found a high prevalence of permanent second molar retention. Most were located in the 
maxilla. The presence of one or multiple retained permanent second molars was significantly 
associated with mutations in COL1A1 or COL1A2 predicted to cause qualitatively changed 
collagen type I. Thus, special emphasis should be put on diagnosing retention in children 
harboring this class of mutations. Early diagnosis is important in order to direct development 
of the occlusion positively and prevent periodontal problems, follicular cysts, pericoronal 
inflammation, and pain. Failure to detect retention may occasionally cause root resorption of 
the permanent first molar. Our clinical experience is that surgical exposure may facilitate 
eruption when retention is diagnosed and no other obstacle (e.g. impacted third molars) is 
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present. Our clinical practice is to pause bisphosphonate treatment 2 weeks before and 6 weeks 
after the surgical procedure in order to minimize the risk of bisphosphonate-related necrosis of 
the jaw. However, an individual assessment must always be done. It is wise to contact the 
Swedish national multidisciplinary pediatric OI team at Astrid Lindgren Children’s Hospital 
before the surgical procedure. 
General management of individuals with OI clinically in dental 
practice 
The dental management of children and adolescents with OI also include other important 
variables. Bleeding and easy bruising is a common feature in heritable connective tissue 
disorders, including OI. The coagulation defect is partly related to the effect of abnormal 
collagen on platelet–endothelial cell interactions and capillary strength (Keegan et al., 2002, 
Malfait & De Paepe, 2009, Siegel et al., 1957). There is a 10-30% frequency of bleeding 
diathesis in individuals with OI, and the risk of bleeding complications when performing oral 
surgery procedures in these children is increased. Thus, it is wise to discuss the case with 
medical colleagues before electing surgical procedures in order to set in prophylaxis or manage 
bleeding complications.   
Craniofacial and dental aberrations are common in individuals with OI. Class III malocclusion, 
lateral open bite, crossbite and agenesis are frequently seen. Our experience is that a restrictive 
approach should be taken to early interceptive treatment. Later signs of aggravating 
malocclusions might occur. When facial growth and dental development are finished 
orthodontic treatment with fixed appliance and/or orthognathic surgery might be necessary. 
The potential presence of atlantoaxial instability in some individuals with OI must always be 
considered. It is characterized by an excess mobility of atlas (C1) and axis (C2) due to the 
manifestation of collagen type I defect in the surrounding ligaments. Before tipping patients 
with OI backward in the dental chair, it is important to be aware of potential involvement of 
this feature and be careful during operative procedures as an incautious handling may result in 
severe spinal cord complications. It may be wise to let the parent lift a child with high fracture 
risk to the operating table.  
Malignant hyperthermia is uncommon but can occur during anesthesia. 
 
 
  57 
FUTURE RESEARCH 
The results of these studies indicate the complexity of the human genome and its resulting 
phenotype. It is obvious that collagen type I mutations do not act in a vacuum. One significant 
variable to be aware of is the difference between the actual DNA sequence change, and the 
resulting protein product and its interactions. The phenotype resulting from the collagen type I 
mutation is an obvious example. It points to the importance of further elucidating potential 
mechanisms underlying the expressed phenotype. Based on the results of these studies, it would 
be desirable to further evaluate the genetic programs governing tooth and craniofacial 
development in OI in animal models.  
One limitation of our studies is that we only assessed nucleotide changes at the DNA level. It 
would be desirable to further evaluate changes at gene expression level by verifying functional 
analysis. A natural continuation of the present results would be to test the effects of specific 
mutations in, for example, animal models. This is also a challenging task. Loss-of-function 
mutations would be the easiest way to test by knockout of specific genes of interest. Several 
animal models have been used in the investigation of OI, fewer have been developed to further 
investigate the dental phenotype. These include the Mov-13 mouse (OI type I), Brittle II mouse 
(OI type II), Oim/Oim mouse (OI type III), and Brittle IV mouse (OI type IV).  
Zebrafish would be a potentially interesting animal model to further develop and evaluate. 
Short generation time, reliable mutagenesis techniques, and a huge number of embryos are 
some of the advantages of a zebrafish model for skeletal dysplasias (Fisher et al., 2003). 
Heterozygous Chihuahua fish express phenotypic similarity to humans and could be a 
promising model to use for further investigation of tooth and craniofacial development and the 
effects of specific gene alterations. Regarding COL1A1, the DNA sequence is highly similar to 
the human sequence. A 76% similarity exists at the amino acid level (Kamoun-Goldrat & Le 
Merrer, 2007). The Chihuahua mutants could be a model for further assessment of tooth and 
craniofacial development in OI based on both molecular defects and the resulting phenotype, 
including misshapen and irregularly shaped bones. Zebrafish homolog models have been used 
to assess several syndromes in recent years; this includes the sec24d model for OI (Sarmah et 
al., 2010).  
We identified several variants of uncertain clinical significance in genes with a known impact 
on tooth development. We critically revised all these variants based on several algorithms to 
assess their potential impact on phenotype. However, in order to be more certain about the 
pathogenicity, functional validation studies are necessary. Here, animal models may be helpful. 
One advantage of animal models is that this approach results in the specific genetic variant 
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effects on the whole organism. Knockouts of specific genes could be used to study the influence 
on other potentially interacting genes. Another interesting aspect could be to study the 
expression of developmental genes at specific locations during the various stages of 
craniofacial and tooth development. This could be done by, for example, tagged antibodies in 
western-blotting or enzyme-linked immunosorbent assay (ELISA). It is intriguing to speculate 
that these kinds of studies could give us more clues about the time- and space-specific 
alterations and interactions during tooth and craniofacial development. In future, more 
knowledge on these genetic alterations may give us better opportunities to guide development 
of the individual in the most favorable way during treatment. In the long run, it is intriguing to 
consider the development of gene therapeutic methods to treat the conditions associated with 
the disease. 
To enable future gene therapeutic alternatives, we need to increase our understanding of the 
underlying genetic changes and its effects. These kinds of studies stress the importance of large 
cohorts of individuals presenting with the rare disease. A further perspective on the first study 
in this thesis would thus be further genetic evaluation of the included individuals. The 
identification of families in whom DGI-II is present opens up the opportunity for later 
investigations of genotype-phenotype correlations. Such evaluation could provide a unique 
opportunity to further elucidate genetic similarities and differences and the expression of the 
disease in an extensive cohort of this rare disease. The focus of such genetic evaluation could 
reasonably be the DSPP gene. 
Finally, considering the results of the fourth study in this thesis, we encourage the use of next-
generation sequencing to identify disease-causing variants in OI and other rare diseases. 
However, to identify potential common variants in individuals presenting with a specific rare 
phenotype, it would be valuable to include more individuals and controls to enable 
discrimination of potential gene candidates. Furthermore, in addition to our in silico 
predictions, investigation of relatives and confirming functional validation is essential for 
identifying true disease-causing variants.  
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